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1. INTRODUCTION {#mbo3915-sec-0001}
===============

Urinary tract infections (UTIs) are among the most common cause of bacterial infections requiring antibiotic treatment (Flores‐Mireles, Walker, Caparon, & Hultgren, [2015](#mbo3915-bib-0013){ref-type="ref"}; Foxman, [2014](#mbo3915-bib-0014){ref-type="ref"}; Hooton & Stamm, [1997](#mbo3915-bib-0022){ref-type="ref"}). The majority of community‐acquired UTIs (70%--95%) and recurrent UTIs are caused by uropathogenic *Escherichia coli* (UPEC) (Flores‐Mireles et al., [2015](#mbo3915-bib-0013){ref-type="ref"}; Nielubowicz & Mobley, [2010](#mbo3915-bib-0059){ref-type="ref"}). The human gut acts as a reservoir for UPEC strains where they form part of the fecal flora (Kaper, Nataro, & Mobley, [2004](#mbo3915-bib-0033){ref-type="ref"}; Moreno et al., [2006](#mbo3915-bib-0056){ref-type="ref"}). Following colonization of the periurethral area, UPEC infect the urinary tract in an ascending manner, resulting in diseases ranging from asymptomatic bacteriuria (ABU), cystitis, pyelonephritis, and sepsis (Hooton, [2012](#mbo3915-bib-0021){ref-type="ref"}). UPEC strains have high genomic diversity and encode numerous virulence factors that differentiate them from non‐UTI‐causing strains (Johnson, [1991](#mbo3915-bib-0029){ref-type="ref"}; Lloyd, Rasko, & Mobley, [2007](#mbo3915-bib-0045){ref-type="ref"}; Najafi, Hasanpour, Askary, Aziemzadeh, & Hashemi, [2018](#mbo3915-bib-0057){ref-type="ref"}; Norinder, Koves, Yadav, Brauner, & Svanborg, [2012](#mbo3915-bib-0060){ref-type="ref"}). These virulence factors contribute to disease progression allowing UPEC to colonize the uroepithelium, produce toxins, scavenge metabolites, and evade the host immune system (Schwab, Jobin, & Kurts, [2017](#mbo3915-bib-0063){ref-type="ref"}; Terlizzi, Gribaudo, & Maffei, [2017](#mbo3915-bib-0071){ref-type="ref"}).

Bacterial colonization is limited in the upper urogenital tract by several mechanisms including urine flow, chemical properties of urine, epithelial cell shedding, influx of immune cells including neutrophils upon bacterial stimulation, and secretion of soluble proteins and peptides by epithelial cells (Spencer, Schwaderer, Becknell, Watson, & Hains, [2014](#mbo3915-bib-0066){ref-type="ref"}; Weichhart, Haidinger, Horl, & Saemann, [2008](#mbo3915-bib-0079){ref-type="ref"}). Secreted proteins and antimicrobial peptides (AMPs) form part of the innate immune defenses of the urogenital tract and act through immunomodulation, indirect anticolonization activity, or direct bacterial killing (Kai‐Larsen et al., [2010](#mbo3915-bib-0032){ref-type="ref"}; Zasloff, [2007](#mbo3915-bib-0080){ref-type="ref"}). AMPs are small (12--50 amino acids), cationic, amphipathic peptides that exert bactericidal action by interacting with anionic bacterial membranes to form pores resulting in bacterial lysis (Jenssen, Hamill, & Hancock, [2006](#mbo3915-bib-0026){ref-type="ref"}). Two types of AMPs are detected in the urogenital tract: defensins that form small disulfide bond‐stabilized ß‐sheets and the α‐helical cathelicidin LL‐37 (Chromek et al., [2006](#mbo3915-bib-0009){ref-type="ref"}; Lehmann et al., [2002](#mbo3915-bib-0042){ref-type="ref"}; Valore et al., [1998](#mbo3915-bib-0075){ref-type="ref"}). In addition, the urogenital tract produces large structured antimicrobial proteins called ribonucleases (RNases) (Spencer et al., [2011](#mbo3915-bib-0067){ref-type="ref"}, [2013](#mbo3915-bib-0068){ref-type="ref"}). Human α‐defensin 5 (HD5), human ß‐defensins (hBD) 1 and 2, LL‐37, and RNase 7 are thought to prevent bacterial colonization as they are constitutively expressed in the urinary tract (Kjolvmark, Akesson, & Pahlman, [2017](#mbo3915-bib-0035){ref-type="ref"}; Spencer et al., [2012](#mbo3915-bib-0065){ref-type="ref"}). During UTIs, production of HD5, hBD2, LL‐37, and RNase 7 increases, suggesting an active role in bacterial clearance (Chromek & Brauner, [2008](#mbo3915-bib-0008){ref-type="ref"}; Chromek et al., [2006](#mbo3915-bib-0009){ref-type="ref"}; Nielsen et al., [2014](#mbo3915-bib-0058){ref-type="ref"}; Spencer et al., [2012](#mbo3915-bib-0065){ref-type="ref"}, [2013](#mbo3915-bib-0068){ref-type="ref"}). Remarkably, increased cathelicidin expression and LL‐37 secretion are triggered a few minutes after bacteria encounter uroepithelial cells. This suggested role for AMPs in UTI immune defense is consistent with reports that UPEC strains are generally more resistant to AMPs than commensal *E. coli* strains that do not colonize the urogenital tract (Chromek et al., [2006](#mbo3915-bib-0009){ref-type="ref"}).

Gram‐negative bacteria use several mechanisms to resist killing by AMPs, including capsules, efflux pumps, LPS modifications, and proteases (Gruenheid & Le Moual, [2012](#mbo3915-bib-0018){ref-type="ref"}). Omptin proteases are found in the Gram‐negative outer bacterial membrane and have a conserved active site with features of both aspartate and serine proteases (Kramer et al., [2001](#mbo3915-bib-0036){ref-type="ref"}; Vandeputte‐Rutten et al., [2001](#mbo3915-bib-0076){ref-type="ref"}). With their active sites facing the extracellular environment, omptins contribute to virulence by cleaving a variety of proteins and peptides (Haiko, Suomalainen, Ojala, Lahteenmaki, & Korhonen, [2009](#mbo3915-bib-0019){ref-type="ref"}). Both substrate specificity and amino acid identity are used to classify omptins into Pla‐like and OmpT‐like subfamilies. Pla readily cleaves the proenzyme plasminogen into active plasmin to promote bacterial dissemination during both bubonic and pneumonic plague (Lathem, Price, Miller, & Goldman, [2007](#mbo3915-bib-0040){ref-type="ref"}; Sodeinde et al., [1992](#mbo3915-bib-0064){ref-type="ref"}; Zimbler, Schroeder, Eddy, & Lathem, [2015](#mbo3915-bib-0082){ref-type="ref"}). OmpT rapidly cleaves and inactivates AMPs, including LL‐37, protamine, and a synthetic peptide optimized to have maximum antibacterial activity called C18G (Brannon, Thomassin, Desloges, Gruenheid, & Le Moual, [2013](#mbo3915-bib-0005){ref-type="ref"}; Stumpe, Schmid, Stephens, Georgiou, & Bakker, [1998](#mbo3915-bib-0069){ref-type="ref"}; Thomassin, Brannon, Gibbs, Gruenheid, & Le Moual, [2012](#mbo3915-bib-0073){ref-type="ref"}). OmpT‐mediated AMP inactivation is thought to support host colonization by some pathogenic *E. coli* strains (Thomassin, Brannon, Gibbs, et al., [2012](#mbo3915-bib-0073){ref-type="ref"}). In addition to OmpT, two OmpT‐like proteases have been described in *E. coli* strains (Kaufmann, Stierhof, & Henning, [1994](#mbo3915-bib-0034){ref-type="ref"}; McPhee et al., [2014](#mbo3915-bib-0054){ref-type="ref"}; Zhuge et al., [2018](#mbo3915-bib-0081){ref-type="ref"}); these genes, called *ompP* and *arlC* (*ompTp*), encode proteins that have approximately 74% amino acid identity to OmpT (GenBank accession numbers: AAC73666.1 (OmpT), BAA97899.1 (OmpP), ADR30001.1 (ArlC)). While the physiological substrates of OmpP and ArlC are unknown, OmpP has been shown to cleave the AMP protamine and ArlC is associated with AMP resistance (Hwang et al., [2007](#mbo3915-bib-0025){ref-type="ref"}; McPhee et al., [2014](#mbo3915-bib-0054){ref-type="ref"}).

The *ompT* gene is present in the genome of 85%--97% of UPEC clinical isolates and is used in epidemiological studies to identify virulent UPEC strains, yet its function across clinical isolates remains unclear (Foxman, Zhang, Palin, Tallman, & Marrs, [1995](#mbo3915-bib-0015){ref-type="ref"}). As OmpT and OmpT‐like omptins play roles in resistance to host‐produced AMPs, we hypothesized that UPEC strains from patients with symptomatic UTIs have high OmpT protease activity. To test this hypothesis, we detected *ompT* and measured OmpT activity in a collection of 58 clinical *E. coli* isolates from groups of patients with infections of differing clinical severity (fecal, ABU, UTI \[cystitis and pyelonephritis\], and sepsis). Heterogeneous OmpT activity was observed, and in some isolates, high protease activity was correlated with the presence of an additional *ompT*‐like gene called *arlC* (*ompTp*). The presence of two OmpT‐like proteases in some UPEC isolates led us to compare the substrate specificity of the three *E. coli* omptins (OmpT, OmpP, and ArlC). We found that OmpT, OmpP, and ArlC all cleave AMPs, although cleavage efficiency of different AMP types varied. Our results suggest that the presence of multiple omptins allows UPEC to cleave at least two major subsets of AMPs encountered during infection.

2. MATERIALS AND METHODS {#mbo3915-sec-0002}
========================

2.1. Bacterial strains and growth conditions {#mbo3915-sec-0003}
--------------------------------------------

58 clinical *E. coli* isolates originating from patients diagnosed with extraintestinal infections or from the urine or stool of healthy individuals were obtained from the Manges collection. Included isolates were randomly selected from the *E. coli* category to ensure they were representative. Isolates were divided into four groups based on disease type. Fecal isolates (*n* = 12) were recovered from the feces of healthy subjects in Québec, Canada (2009--2010), ABU isolates (*n* = 10) were from patients with asymptomatic bacteriuria in California, USA (2005--2006) (Manges, Johnson, & Riley, [2004](#mbo3915-bib-0048){ref-type="ref"}), UTI isolates (*n* = 24) were recovered from patients with cystitis in Québec, Canada (2005--2007) (Manges, Tabor, Tellis, Vincent, & Tellier, [2008](#mbo3915-bib-0050){ref-type="ref"}) and cystitis or pyelonephritis in California, USA (1999--2000) (Larsen, Cosentino, Dietrich, & Riley, [2004](#mbo3915-bib-0046){ref-type="ref"}), and sepsis isolates (*n* = 12) were from patients with sepsis in California, USA (2001--2003) (Manges, Perdreau‐Remington, Solberg, & Riley, [2006](#mbo3915-bib-0049){ref-type="ref"}). Bacterial strains used in this study are listed in Table [1](#mbo3915-tbl-0001){ref-type="table"}. Bacteria were routinely cultured in lysogeny broth (LB; 10% (w/v) tryptone, 5% (w/v) yeast extract, 10% (w/v) NaCl)) or in N‐minimal medium (50 mM Bis‐Tris, 5 mM KCl, 7.5 mM (NH~4~)~2~SO~4~, 0.5 mM K~2~SO~4~, 0.5 mM KH~2~PO~4~, 0.1% casamino acids) adjusted to pH 7.5, supplemented with 1.4% glucose and 1 mM MgCl~2~ (UPEC isolates) or with 0.5% glucose and 1 mM MgCl~2~ (all other strains). Bacteria were cultured at 37°C with aeration (220 rpm).

###### 

Strains and plasmids used in this study

  Strains         Description                                                                                                                           Source
  --------------- ------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------
  XL1‐Blue        *endA1 gyrA96*(nal^R^) *thi‐1 recA1 relA1 lac glnV44* F\'\[ ::Tn10 *proAB* ^+^ *lacI* ^q^ Δ(*lacZ*)M15\] *hsdR17*(r~K~ ^−^m~K~ ^+^)   Stratagene
  GMS 002A        O11:NM; coded as Fecal 1                                                                                                              (Aslam et al., [2014](#mbo3915-bib-0002){ref-type="ref"})
  GMS 003A        Coded as Fecal 2                                                                                                                      Manges strain collection
  GMS 005A        Coded as Fecal 3                                                                                                                      Manges strain collection
  GMS 006E        Coded as Fecal 4                                                                                                                      Manges strain collection
  GMS 008A        Coded as Fecal 5                                                                                                                      Manges strain collection
  GMS 009B        Coded as Fecal 6                                                                                                                      (Aslam et al., [2014](#mbo3915-bib-0002){ref-type="ref"})
  GMS 010A        Coded as Fecal 7                                                                                                                      Manges strain collection
  GMS 012A        Coded as Fecal 8                                                                                                                      Manges strain collection
  GMS 015A        Coded as Fecal 9                                                                                                                      Manges strain collection
  GMS 016D        Coded as Fecal 10                                                                                                                     Manges strain collection
  GMS 017A        Coded as Fecal 11                                                                                                                     Manges strain collection
  GMS 018A        Coded as Fecal 12                                                                                                                     Manges strain collection
  10001U001       Coded as asymptomatic bacteriuria 1                                                                                                   (Manges, Johnson, et al., [2004](#mbo3915-bib-0048){ref-type="ref"})
  10003U002       Coded as asymptomatic bacteriuria 2                                                                                                   (Manges, Johnson, et al., [2004](#mbo3915-bib-0048){ref-type="ref"})
  10004U001       Coded as asymptomatic bacteriuria 3                                                                                                   (Manges, Johnson, et al., [2004](#mbo3915-bib-0048){ref-type="ref"})
  10013U005       Coded as asymptomatic bacteriuria 4                                                                                                   (Manges, Johnson, et al., [2004](#mbo3915-bib-0048){ref-type="ref"})
  10014U005       Coded as asymptomatic bacteriuria 5                                                                                                   (Manges, Johnson, et al., [2004](#mbo3915-bib-0048){ref-type="ref"})
  10017U005       Coded as asymptomatic bacteriuria 6                                                                                                   (Manges, Johnson, et al., [2004](#mbo3915-bib-0048){ref-type="ref"})
  1,001006        Coded as asymptomatic bacteriuria 7                                                                                                   (Manges, Johnson, et al., [2004](#mbo3915-bib-0048){ref-type="ref"})
  10005004        Coded as asymptomatic bacteriuria 8                                                                                                   (Manges, Johnson, et al., [2004](#mbo3915-bib-0048){ref-type="ref"})
  10006001        Coded as asymptomatic bacteriuria 9                                                                                                   (Manges, Johnson, et al., [2004](#mbo3915-bib-0048){ref-type="ref"})
  10012007        Coded as asymptomatic bacteriuria 10                                                                                                  (Manges, Johnson, et al., [2004](#mbo3915-bib-0048){ref-type="ref"})
  CLSC 36         O1:H42; isolated from a patient with cystitis; coded as UTI 1                                                                         (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"})
  MSHS 100        O2:H7; isolated from a patient with cystitis; coded as UTI 2                                                                          (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"})
  MSHS 1,070      Isolated from a patient with cystitis; coded as UTI 3                                                                                 (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"})
  MSHS 233        O9:H32; isolated from a patient with cystitis; coded as UTI 4                                                                         (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"})
  MSHS 434        O73:H18; isolated from a patient with cystitis; coded as UTI 5                                                                        (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"})
  MSHS 472        O82:NM; isolated from a patient with cystitis; coded as UTI 6                                                                         (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"})
  MSHS 635        Isolated from a patient with cystitis; coded as UTI 7                                                                                 (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"})
  MSHS 637        Isolated from a patient with cystitis; coded as UTI 8                                                                                 (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"})
  MSHS 689        Isolated from a patient with cystitis; coded as UTI 9                                                                                 (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"})
  MSHS 415        O6:H1; isolated from a patient with cystitis; coded as UTI 10                                                                         (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"})
  MSHS 133        O24:NM; isolated from a patient with cystitis; coded as UTI 11                                                                        (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"})
  MSHS 769        O4:H5; isolated from a patient with cystitis; coded as UTI 12                                                                         (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"})
  UTI PI 486      O11:Neg; isolated from a patient with pyelonephritis; coded as UTI 13                                                                 (Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"})
  UTI PI 141      X19; isolated from a patient with pyelonephritis; coded as UTI 14                                                                     (Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"})
  UTI PI 147      Isolated from a patient with cystitis; coded as UTI 15                                                                                (Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"})
  UTI PI 192      Isolated from a patient with cystitis; coded as UTI 16                                                                                (Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"})
  UTI PI 240      Isolated from a patient with cystitis; coded as UTI 17                                                                                (Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"})
  UTI PI 247      Isolated from a patient with cystitis; coded as UTI 18                                                                                (Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"})
  UTI PI 259      Isolated from a patient with cystitis; coded as UTI 19                                                                                (Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"})
  UTI PI 268      Isolated from a patient with cystitis; coded as UTI 20                                                                                (Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"})
  UTI PI 280      Isolated from a patient with cystitis; coded as UTI 21                                                                                (Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"})
  UTI PI 374      O18; isolated from a patient with cystitis; coded as UTI 22                                                                           (Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"})
  UTI PI 20       Isolated from a patient with cystitis; coded as UTI 23                                                                                (Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"})
  UTI PI 116      Isolated from a patient with cystitis; coded as UTI 24                                                                                (Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"})
  W26653          O15; isolated from a patient with sepsis; coded as sepsis 1                                                                           (Manges et al., [2006](#mbo3915-bib-0049){ref-type="ref"})
  W55291          O77; isolated from a patient with sepsis; coded as sepsis 2                                                                           (Manges et al., [2006](#mbo3915-bib-0049){ref-type="ref"})
  X19714          O86; isolated from a patient with sepsis; coded as sepsis 3                                                                           (Manges et al., [2006](#mbo3915-bib-0049){ref-type="ref"})
  X37350          O73; isolated from a patient with sepsis; coded as sepsis 4                                                                           (Manges et al., [2006](#mbo3915-bib-0049){ref-type="ref"})
  X47726          O11; isolated from a patient with sepsis; coded as sepsis 5                                                                           (Manges et al., [2006](#mbo3915-bib-0049){ref-type="ref"})
  S49894          O102; isolated from a patient with sepsis; coded as sepsis 6                                                                          (Manges et al., [2006](#mbo3915-bib-0049){ref-type="ref"})
  H15             O153; isolated from a patient with sepsis; coded as sepsis 7                                                                          (Manges et al., [2006](#mbo3915-bib-0049){ref-type="ref"})
  F46700          Isolated from a patient with sepsis; coded as sepsis 8                                                                                (Manges et al., [2006](#mbo3915-bib-0049){ref-type="ref"})
  F55268          Isolated from a patient with sepsis; coded as sepsis 9                                                                                (Manges et al., [2006](#mbo3915-bib-0049){ref-type="ref"})
  M32569          Isolated from a patient with sepsis; coded as sepsis 10                                                                               (Manges et al., [2006](#mbo3915-bib-0049){ref-type="ref"})
  M4026           Isolated from a patient with sepsis; coded as sepsis 11                                                                               (Manges et al., [2006](#mbo3915-bib-0049){ref-type="ref"})
  M49611          Isolated from a patient with sepsis; coded as sepsis 12                                                                               (Manges et al., [2006](#mbo3915-bib-0049){ref-type="ref"})
  CFT073          Uropathogenic *E. coli* O6:K2:H1                                                                                                      (Mobley et al., [1990](#mbo3915-bib-0055){ref-type="ref"})
  CFT073∆*ompT*   Uropathogenic *E. coli* O6:K2:H1 ∆*ompT*                                                                                              (Brannon et al., [2013](#mbo3915-bib-0005){ref-type="ref"})
  BL21            F^--^ *dcm ompT hsdS~B~* (r~B~ ^--^ m~B~ ^--^) *gal*                                                                                  Novagen
  BL21(pWSK129)   BL21(DE3) containing plasmid pWSK129                                                                                                  This study
  BL21(p*ompT*)   BL21(DE3) expressing *ompT* from pWSK*ompT*                                                                                           This study
  BL21(p*ompP*)   BL21(DE3) expressing *ompP* from pWSK*ompP*                                                                                           This study
  BL21(p*arlC*)   BL21(DE3) expressing *arlC* from pWSK*arlC*                                                                                           This study
  BL21(p*pla*)    BL21(DE3) expressing *pla* from pWSK*pla*                                                                                             This study
  Plasmids                                                                                                                                               
  pWSK129         Low‐copy‐number plasmid (Kan^R^)                                                                                                      (Wang & Kushner, [1991](#mbo3915-bib-0077){ref-type="ref"})
  pWSK*arlC*      *arlC* from Cys 6 cloned into pWSK129                                                                                                 This study
  pWSK*pla*       *pla* cloned into pWSK129                                                                                                             This study
  pWSK*ompT*      *ompT* from isolate Cys 6 cloned into pWSK129                                                                                         This study
  pWSK*ompP*      *ompP* from XL1‐Blue cloned into pWSK129                                                                                              This study
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2.2. Multiplex PCR of UPEC virulence genes {#mbo3915-sec-0004}
------------------------------------------

Total DNA (genomic and large plasmid DNA) was isolated using the Puregene Yeast/Bact. kit (Qiagen). Phylogenetic groups were determined as described in Clermont, Bonacorsi, and Bingen ([2000](#mbo3915-bib-0010){ref-type="ref"}), using primer pairs listed in Table [2](#mbo3915-tbl-0002){ref-type="table"}. To detect virulence genes present in the isolates, primer sequences were obtained from previous studies (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"}) or designed *de novo* for this study (Table [2](#mbo3915-tbl-0002){ref-type="table"}). Three multiplex PCR experiments were performed as follows: pool 1: *hylA* (1,177 bp), *papAH* (720 bp), *fimH* (508 bp), *kpsMTIII* (392 bp), and *papEF* (336 bp); pool 2: *papC* (200 bp), *sfaS* (240 bp), *cnf1* (498 bp), *fyuA* (880 bp), *iutA* (300 bp), and *kpsMTII* (272 bp); pool 3: *arlC* (852 bp), *ompT* (670 bp), *fimH* (508 bp), and *ompP* (648 bp).

###### 

Primers used in this study

  Name         Sequence 5--3′[a](#mbo3915-note-0003){ref-type="fn"}   Use                   Source
  ------------ ------------------------------------------------------ --------------------- --------------------------------------------------------------------------------
  iutA_f       GGCTGGACATCATGGGAACTGG                                 Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  iutA_r       CGTCGGGAACGGGTAGAATCG                                  Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  fimH_f       TGCAGAACGGATAAGCCGTGG                                  Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  fimH_r       GCAGTCACCTGCCCTCCGGTA                                  Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  papAH_f      ATGGCAGTGGTGTCTTTTGGTG                                 Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  papAH_r      CGTCCCACCATACGTGCTCTTC                                 Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  papC_f       GTGGCAGTATGAGTAATGACCGTTA                              Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  papC_r       ATATCCTTTCTGCAGGGATGCAATA                              Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  papEF_f      GCAACAGCAACGCTGGTTGCATCAT                              Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  papEF_r      AGAGAGAGCCACTCTTATACGGACA                              Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  sfaS_f       GTGGATACGACGATTAACTGTG                                 Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  sfaS_r       CCGCCAGCATTCCCTGTATTC                                  Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  fyuA_f       TGATTAACCCCGCGACGGGAA                                  Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  fyuA_r       CGCAGTAGGCACGATGTTGTA                                  Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  kpsMII_f     GCGCATTTGCTGATACTGTTG                                  Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  kpsMII_r     CATCCAGACGATAAGCATGAGCA                                Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  kpsMIII_f    TCCTCTTGCTACTATTCCCCCT                                 Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  kpsMIII_r    AGGCGTATCCATCCCTCCTAAC                                 Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  cnf−1_f      AAGATGGAGTTTCCTATGCAGGAG                               Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  cnf−1_r      CATTCAGAGTCCTGCCCTCATTATT                              Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  hlyA_f       AACAAGGATAAGCACTGTTCTGGCT                              Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  hlyA_r       ACCATATAAGCGGTCATTCCCGTCA                              Multiplex PCR         (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"})
  ompT_mf      TTTGATGCCCCAGATATCTATCGG                               Multiplex PCR         This study
  ompT_mr      GGCTTTCCTGATATCCGGCCATG                                Multiplex PCR         This study
  arlC_mf      GATTCTTGCTACTGCACTCTCAGCTCC                            Multiplex PCR         This study
  arlC_mr      CTGGAGTACAGAGAAGTATCACC                                Multiplex PCR         This study
  ompP_mf      TGCTTCTGATTTCTTCGGCC                                   Multiplex PCR         This study
  ompP_mr      GTAGTTTGTCTTACATAATGCTC                                Multiplex PCR         This study
  chuA_f       GACGAACCAACGGTCAGGAT                                   Phylogenetic typing   (Clermont et al., [2000](#mbo3915-bib-0010){ref-type="ref"})
  chuA_r       TGCCGCCAGTACCAAAGACA                                   Phylogenetic typing   (Clermont et al., [2000](#mbo3915-bib-0010){ref-type="ref"})
  yjaA_f       TGAAGTGTCAGGAGACGCTG                                   Phylogenetic typing   (Clermont et al., [2000](#mbo3915-bib-0010){ref-type="ref"})
  yjaA_r       ATGGAGAATGCGTTCCTCAAC                                  Phylogenetic typing   (Clermont et al., [2000](#mbo3915-bib-0010){ref-type="ref"})
  TSPE4.C2_f   GAGTAATGTCGGGGCATTCA                                   Phylogenetic typing   (Clermont et al., [2000](#mbo3915-bib-0010){ref-type="ref"})
  TSPE4.C2_r   CGCGCCAACAAAGTATTACG                                   Phylogenetic typing   (Clermont et al., [2000](#mbo3915-bib-0010){ref-type="ref"})
  ompT_cf      CATG[TCTAGA]{.ul}CCACGACTTAGAAGTTCCTAGAACG             Cloning               This study
  ompT_cr      GC[GAGCTC]{.ul}AAATCTGGTTAACTTCGTTAA                   Cloning               This study
  ompP_cf      GCATAG[TCTAGA]{.ul}TCCTGTAGTTGCGTCAGGCCCTCCA           Cloning               This study
  ompP_cr      GCATAG[CTGCAG]{.ul}TCCGGGTAATCCAGGTCCGCCACT            Cloning               This study
  arlC_cf      CATG[TCTAGA]{.ul}CCCGGCATAAAGTGTCC                     Cloning               This study
  arlC_cr      CTAG[GAGCTC]{.ul}ATCGTTGAGCACATATAC                    Cloning               This study
  ompT_sf      ATGCGGGCGAAACTTCTGGGAATAG                              Southern blot probe   This study
  ompT_sr      TCCCAATTAATTGCACCTTTAATAATT                            Southern blot probe   This study
  arlC_sf      GATTCTTGCTACTGCACTCTCAGCTCC                            Southern blot probe   This study
  arlC_sr      CTAG[GAGCTC]{.ul}ATCGTTGAGCACATATAC                    Southern blot probe   This study
  rpoD_qf      GCTGGAAGAAGTGGGTAAAC                                   qPCR                  This study
  rpoD_qr      TAATCGTCCAGGAAGCTACG                                   qPCR                  This study
  ompT_qf      CAGCGGCTGGGTGGAAGCAT                                   qPCR                  (Thomassin, Brannon, Gibbs, et al., [2012](#mbo3915-bib-0073){ref-type="ref"})
  ompT_qr      ACCCGATTCCATGCGCCTTCA                                  qPCR                  (Thomassin, Brannon, Gibbs, et al., [2012](#mbo3915-bib-0073){ref-type="ref"})
  arlC_qf      AGGATCACCTATCGTAGCGATGT                                qPCR                  This study
  arlC_qf      CGGTTCCATGTTCCTTCGACATAA                               qPCR                  This study

Restriction sites are underlined.
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2.3. Fluorescence resonance energy transfer (FRET) activity assay {#mbo3915-sec-0005}
-----------------------------------------------------------------

The FRET substrate containing a dibasic motif (RK) in its center (2Abz‐SLGRKIQI‐K(Dnp)‐NH2) was purchased from Anachem. Bacteria were grown in N‐minimal medium to mid‐exponential phase and normalized to an OD~595nm~ of 0.5. Bacterial cells were pelleted and resuspended in phosphate‐buffered saline (PBS). Bacteria (\~2.25 × 10^7^ CFU in 75 µl) were mixed in a 96‐well plate with 75 µl of the FRET substrate (final concentration 3 μM). Fluorescence (λ Ex 325 nm, λ Em 430 nm) was monitored for 1 hr at 25°C using a Biotek FLx800 plate reader. Data were normalized by subtracting the background fluorescence of the FRET substrate in PBS.

2.4. Plasmid construction {#mbo3915-sec-0006}
-------------------------

The *ompT* and *arlC* genes were PCR‐amplified from DNA isolated from the UPEC UTI clinical isolate 6, also called cystitis 6, using their respective primer pairs ompT_cf/ompT_cr and arlC_cf/arlC_cr (Table [2](#mbo3915-tbl-0002){ref-type="table"}). PCR fragments were treated with XbaI and SacI and ligated into plasmid pWSK129 treated with the same enzymes, generating plasmids pWSK*ompT* and pWSK*arlC* (Table [1](#mbo3915-tbl-0001){ref-type="table"}). The *ompP* gene was PCR‐amplified from XL1‐Blue DNA using primer pair ompP_cf/ompP_cr. PCR products were treated with XbaI and PstI and ligated into pWSK129 treated with the same enzymes to generate plasmid pWSK*ompP.* The *pla* gene under control of the *croP* promoter was subcloned from pYC*pla* (Brannon, Burk, et al., [2015](#mbo3915-bib-0004){ref-type="ref"}) using XbaI and SacI and ligated into pWSK129 previously treated with the same enzymes, generating pWSK*pla*.

2.5. Southern blotting {#mbo3915-sec-0007}
----------------------

Total DNA was isolated and treated with EcoRV. Southern blotting and hybridization were performed as previously described (Taylor, Ouimet, Wargachuk, & Marczynski, [2011](#mbo3915-bib-0070){ref-type="ref"}) using Hybond‐XL membranes. Probes for *ompT* and *arlC* were PCR‐generated using primer pairs ompT_sf/ompT_sr and arlC_sf/arlC_sr, respectively (Table [2](#mbo3915-tbl-0002){ref-type="table"}). Probes were radiolabeled with dATP \[α‐32P\] using the RadPrime kit (Invitrogen). The pWSK*arlC* plasmid was used as the positive control for the *arlC* probe.

2.6. Quantitative RT‐PCR {#mbo3915-sec-0008}
------------------------

Quantitative RT‐PCR (qPCR) was performed as previously described (Thomassin, Brannon, Gibbs, et al., [2012](#mbo3915-bib-0073){ref-type="ref"}). Briefly, bacterial strains were grown to an OD~595nm~ of 0.5 in N‐minimal medium. Total RNA was isolated using TRIzol reagents (Invitrogen) and treated with TURBO DNase I (Ambion) to remove residual DNA. The absence of DNA was confirmed by qPCR using the primer pair rpoD_qf/rpoD_qr. RNA (100 ng) was reverse‐transcribed using Superscript II (Invitrogen) with 0.5 μg of random hexamer primers. A reaction mixture without Superscript II was also included and was used as the negative control. qPCRs were performed in a Rotor‐Gene 3,000 thermal cycler (Corbett Research) using the Maxima SYBR Green qPCR kit (Thermo Scientific), according to the manufacturer\'s instructions. Primers used are listed in Table [2](#mbo3915-tbl-0002){ref-type="table"}. The relative expression levels were calculated by normalizing the threshold cycle (*C* ~T~) of *ompT* and *arlC* transcripts to the *C* ~T~ of *rpoD* using the 2^‐Δ^ *^C^* ^T^ method (Livak & Schmittgen, [2001](#mbo3915-bib-0044){ref-type="ref"}).

2.7. Whole‐genome sequencing {#mbo3915-sec-0009}
----------------------------

Sequencing was performed on a PacBio platform (Pacific Biosciences). Genomic DNA samples were purified using the Gentra® Puregene® kit (Qiagen) and sheared to 20 kb using g‐tubes (Covaris). Libraries were prepared using the template preparation kit from Pacific Biosciences. A single SMRT cell was sequenced to generate datasets including unique subreads with a minimum length of 3 kb. Genome assemblies of sequence reads were generated using a combination of HGAP/Celera/Quiver following Pacific Biosciences recommendations. The complete chromosome and plasmid sequences were submitted to GenBank. The BioProject accession numbers are as follows: PRJNA551561 (cystitis 1), PRJNA551565 (cystitis 6), and PRJNA551566 (cystitis 11).

2.8. Preparation of whole‐cell lysates and outer membrane fractions {#mbo3915-sec-0010}
-------------------------------------------------------------------

Bacteria were grown in N‐minimal medium until mid‐exponential phase and normalized to an OD~595nm~ of 0.5. For whole‐cell lysate samples, bacterial cells were pelleted and resuspended in 1/10 volume of 2X ESB (Thomas et al., [2005](#mbo3915-bib-0072){ref-type="ref"}). Outer membrane fractions were isolated as follows: bacterial cultures were centrifuged at 3, 600 *g* for 10 min, and pellets were resuspended in 1.5 ml low‐salt buffer (100 mM NaPi buffer \[pH 7\], 5 mM EDTA, and 10% glycerol). Samples were supplemented with 10 µl PMSF and sonicated. Samples were then centrifuged at 3,600 *g* for 10 min. Supernatants were collected and centrifuged at 100,000 *g* for 30 min at 4°C. Pellets were resuspended in 2 ml sarcosyl buffer (10 mM Tris \[pH 7.5\], 5 mM MgCl~2~, and 2% sarcosyl) and incubated for 30 min at 10°C. Samples were then centrifuged for 60 min at 100,000 *g*, and the pellet containing outer membranes was resuspended in buffer (20 mM Tris‐HCl pH 7.5 and 10% glycerol). Outer membrane samples were combined 1:1 with 2X ESB and boiled for 10 min prior to loading samples on an SDS‐PAGE gel.

2.9. Western blotting {#mbo3915-sec-0011}
---------------------

Whole‐cell lysate and outer membrane fractions were resolved on a 10% SDS‐PAGE gel and transferred to a polyvinylidene fluoride membrane. Membranes were blocked for 1 hr in Tris‐buffered saline (TBS) supplemented with 5% skim milk, and OmpT was detected using the polyclonal anti‐CroP antibody as described in Thomassin, Brannon, Gibbs, et al. ([2012](#mbo3915-bib-0073){ref-type="ref"}). Membranes were washed extensively with TBS and incubated for 1 hr with a goat anti‐rabbit secondary antibody conjugated with HRP. Membranes were washed and developed using chemiluminescent HRP substrate.

2.10. Plasminogen activation assay {#mbo3915-sec-0012}
----------------------------------

Bacteria were grown in N‐minimal medium to mid‐exponential phase and normalized to an OD~595nm~ of 0.5. Bacterial cells were pelleted and resuspended in ½ volume of phosphate‐buffered saline (PBS; final 6 x10^8^ CFU/mL). In a 96‐well plate, 178 μL of bacteria and 20 μL of 45 mM VLKpNA (Sigma‐Aldrich) were combined. Baseline assays were performed at OD~405nm~. After 5 min, 4 μg of plasminogen substrate was added and absorbance (405 nm) was measured every 10 min for 400 min at 37°C with agitation before every reading.

2.11. Proteolytic cleavage of AMPs {#mbo3915-sec-0013}
----------------------------------

Bacteria were grown in N‐minimal medium to mid‐exponential phase, washed, and normalized to an OD~595nm~ of 0.5 in PBS. Aliquots of bacteria (10^7^ CFU) were combined 1:4 (v/v) with 2 μg/µL LL‐37, mCRAMP, C18G or Magainin II (BioChemia), or 1 μg/µL RNase 7 and incubated at room temperature for various time points. Bacteria were separated from peptide cleavage products by centrifugation, and supernatants were combined 1:1 with 2X ESB, then boiled and frozen at −20°C. Peptide cleavage products were resolved on 10%--20% Tris‐Tricine gels (Bio‐Rad), and RNase 7 samples were resolved on 20% SDS‐PAGE gels. Peptides were fixed in the gel by incubation in 20% (v/v) glutaraldehyde for 30 min; gels were rinsed with water and peptides stained for 1h with Coomassie blue G‐250 stain. Gels were destained in 20% (v/v) acetic acid.

2.12. Circular dichroism spectroscopy {#mbo3915-sec-0014}
-------------------------------------

Experiments were performed on a Jasco J‐810 spectropolarimeter (Easton, MD). AMPs (200 µg/ml in PBS) were placed in a quartz cuvette with a path length of 0.1 cm, and spectra were recorded from 260 to 195 nm. Samples were scanned three times at 20°C using a bandwidth of 1 nm, a time response of 2 s, and a scan rate of 100 nm/min. Spectra were corrected by subtracting the background spectrum of PBS, and values were converted from ellipticity to mean residue ellipticity (MRE; degree × cm^2^ × dmol^−1^).

2.13. Statistical analyses {#mbo3915-sec-0015}
--------------------------

Data were analyzed using GraphPad Prism software. Normality was verified using the D'Agostino--Pearson normality test. Fisher\'s exact test was performed to compare incidence of virulence genes within severity groups of UPEC clinical isolates. FRET activity was assessed using a two‐way ANOVA with Tukey\'s post hoc test. *P* value ≤ 0.05 was considered significantly different.

3. RESULTS {#mbo3915-sec-0016}
==========

3.1. Phylogenetic and virulence profile of UPEC isolates {#mbo3915-sec-0017}
--------------------------------------------------------

UPEC isolates from patients with different disease severities were obtained from the Manges collection (Manges et al., [2018](#mbo3915-bib-0043){ref-type="ref"}, [2001](#mbo3915-bib-0047){ref-type="ref"}, [2006](#mbo3915-bib-0049){ref-type="ref"}; Manges, Dietrich, et al., [2004](#mbo3915-bib-0046){ref-type="ref"}; Manges, Johnson, et al., [2004](#mbo3915-bib-0048){ref-type="ref"}). Although UPEC strains are heterogeneous, clinical isolates from UTIs predominantly belong to *E. coli* phylogenetic groups B2 and D (Johnson, Delavari, Kuskowski, & Stell, [2001](#mbo3915-bib-0030){ref-type="ref"}). To confirm that our isolates are generally representative of UPEC clinical strains, we determined the phylogenetic grouping of our 58 clinical isolates categorized into the fecal (*n* = 12), ABU (*n* = 10), UTI (cystitis and pyelonephritis, *n* = 24), and sepsis (*n* = 12) groups. Most isolates from the ABU and UTI groups associated with UTIs belong to the phylogenetic group B2 and, to a lesser extent, D (Table [3](#mbo3915-tbl-0003){ref-type="table"}). In contrast, isolates from the sepsis group were predominantly from group D (Table [3](#mbo3915-tbl-0003){ref-type="table"}). Finally, isolates from the fecal group had the most variable phylogenetic grouping with 5/12 isolates belonging to phylogenetic groups A and B1 (Table [3](#mbo3915-tbl-0003){ref-type="table"}). Overall, this distribution is in agreement with previous reports, showing that UPEC strains mainly belong to *E. coli* phylogenetic groups B2 and D (Johnson et al., [2001](#mbo3915-bib-0030){ref-type="ref"}).

###### 

Phylogenetic distribution of UPEC clinical isolates

                      Phylogenetic groups   (B2 + D)/Total             
  ------------------- --------------------- ---------------- ---- ---- -------
  Fecal (*n* = 12)    4                     1                3    4    7/12
  ABU (*n* = 10)      2                     1                5    2    7/10
  UTI (*n* = 24)      3                     3                11   7    18/24
  Sepsis (*n* = 12)   0                     2                0    10   10/12
  Total (*n* = 58)    9                     7                19   23   42/58

John Wiley & Sons, Ltd

The 58 isolates were further characterized using multiplex PCR to detect 12 recognized UPEC virulence genes (Table [4](#mbo3915-tbl-0004){ref-type="table"}). Our data showed variations consistent with previous studies reporting that UPEC is a heterogeneous pathotype (Marschall et al., [2012](#mbo3915-bib-0051){ref-type="ref"}; Maynard et al., [2004](#mbo3915-bib-0052){ref-type="ref"}; Norinder et al., [2012](#mbo3915-bib-0060){ref-type="ref"}; Poey, Albini, Saona, & Lavina, [2012](#mbo3915-bib-0061){ref-type="ref"}). The *fimH* gene, involved in UPEC adherence, was present in all but 2 ABU isolates (Table [4](#mbo3915-tbl-0004){ref-type="table"}). There was a difference in the distribution of virulence genes *fyuA* and *ompT* for which the incidence was significantly higher in symptomatic (i.e., UTI and sepsis) groups than asymptomatic (i.e., fecal and ABU) groups (Table [4](#mbo3915-tbl-0004){ref-type="table"}). No other genes showed a significant difference in incidence between asymptomatic and symptomatic groups. In agreement with previous studies, we found that *ompT* is present in 89% of the UPEC isolates associated with symptomatic infections (Table [4](#mbo3915-tbl-0004){ref-type="table"}).

###### 

Prevalence of virulence factors in UPEC clinical isolates

  Gene         Fecal (*n* = 12)   ABU (*n* = 10)   UTI (*n* = 24)   Sepsis (*n* = 12)   *P* value[a](#mbo3915-note-0004){ref-type="fn"}
  ------------ ------------------ ---------------- ---------------- ------------------- -------------------------------------------------
  *iutA*       1                  6                14               12                  *0.0541*
  *fimH*       12                 8                24               12                  *0.5508*
  *papAH*      3                  6                10               10                  *0.4173*
  *papC*       3                  6                12               10                  *0.4263*
  *papEF*      4                  7                12               10                  *0.4550*
  *sfaS*       1                  1                4                0                   *1.0000*
  *fyuA*       9                  7                23               11                  ***0.0435***
  *kpsMTII*    7                  7                14               8                   *1.0000*
  *kpsMTIII*   0                  0                2                0                   *0.5203*
  *cnf1*       4                  4                8                0                   *0.3641*
  *hylA*       4                  3                5                1                   *0.2078*
  *ompT*       7                  7                22               10                  ***0.0418***

*P* value determined by Fisher\'s exact test, statistical significance (*p* ≤ 0.05) is indicated in bold.
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3.2. Variability of omptin proteolytic activities among UPEC isolates {#mbo3915-sec-0018}
---------------------------------------------------------------------

OmpT preferentially cleaves substrates between two consecutive basic residues (Dekker, Cox, Kramer, & Egmond, [2001](#mbo3915-bib-0011){ref-type="ref"}; McCarter et al., [2004](#mbo3915-bib-0053){ref-type="ref"}). Therefore, to assess OmpT proteolytic activity we measured cleavage of a FRET substrate (2Abz‐SLGRKIQI‐K(Dnp)‐NH~2~) that contains a dibasic motif in its center (Brannon, Burk, et al., [2015](#mbo3915-bib-0004){ref-type="ref"}; Brannon et al., [2013](#mbo3915-bib-0005){ref-type="ref"}; McPhee et al., [2014](#mbo3915-bib-0054){ref-type="ref"}; Thomassin, Brannon, Gibbs, et al., [2012](#mbo3915-bib-0073){ref-type="ref"}). Cleavage of the substrate by the 58 clinical *E. coli* isolates was monitored by measuring fluorescence emission over time and compared with substrate cleavage by the previously characterized reference UPEC strain CFT073 (Brannon et al., [2013](#mbo3915-bib-0005){ref-type="ref"}). As shown in Figure [1](#mbo3915-fig-0001){ref-type="fig"}a, omptin activity of the isolates was heterogeneous between groups. Isolates for which the *ompT* gene was not detected by PCR showed basal activity levels (red triangles in Figure [1](#mbo3915-fig-0001){ref-type="fig"}a), whereas isolates harboring the *ompT* gene showed a wide range of omptin activity. The omptin activity of the isolates of the fecal group was significantly lower than that of the 2 symptomatic groups (UTI and sepsis) (Figure [1](#mbo3915-fig-0001){ref-type="fig"}a). The mean activity of the isolates from the fecal group (0.75 ± 0.5) was lower than that of strain CFT073. In contrast, the activity means of the symptomatic groups (1.54 ± 0.66 and 1.71 ± 0.66) were higher than those of CFT073. Extensive variability in omptin activity was also observed within groups (Figure [1](#mbo3915-fig-0001){ref-type="fig"}a). The UTI group exhibited the most heterogeneous omptin activity, and some isolates from the UTI group had threefold higher omptin activity than CFT073. Together, these results indicate that omptin activity is variable among fecal and UPEC clinical isolates.

![Omptin protease activity and distribution in clinical isolates. (a) Omptin activity was determined by monitoring fluorescence, indicative of FRET substrate cleavage, for 60 min. Data points indicate mean fold change in fluorescence of each isolate over the mean fold change in fluorescence of reference UPEC strain CFT073 $\left( \frac{{\text{Area\ under\ the\ curve}\mspace{6mu}}\left( \text{AUC} \right){\mspace{6mu}\text{clinical\ isolate}}}{\text{AUC\ CFT073}} \right)$ from triplicate samples. Bars represent mean ± *SD* fold change in fluorescence for each group. Bacteria that contain the *ompT* gene are indicated by circles, and those that do not contain *ompT* are indicated by triangles. Indicated in green or purple are isolates that contain *arlC*. Statistical analysis was performed by one‐way ANOVA followed by Tukey\'s *post hoc* test using GraphPad Prism software (NS, not significant; \**p* ≤ 0.05; \*\**p* ≤ 0.01). (b) Multiplex PCR of *arlC* (852 bp), *ompT* (670 bp), and *fimH* (508 bp) from each of the clinical isolates. Amplification of *fimH* was used as a positive control. Numbers indicate isolate number for each group. Data are representative of at least three independent experiments](MBO3-8-e915-g001){#mbo3915-fig-0001}

3.3. OmpT‐like proteases in UPEC {#mbo3915-sec-0019}
--------------------------------

In addition to the chromosomally encoded *ompT* gene, plasmid‐borne *ompT*‐like genes *ompP* and *arlC* are present in several *E. coli* strains (Kaufmann et al., [1994](#mbo3915-bib-0034){ref-type="ref"}; McPhee et al., [2014](#mbo3915-bib-0054){ref-type="ref"}; Zhuge et al., [2018](#mbo3915-bib-0081){ref-type="ref"}). These OmpT‐like proteins are approximately 74% identical to OmpT. To determine whether the presence of *ompT*‐like genes in some isolates may account for the heterogeneity of OmpT activity observed in Figure [1](#mbo3915-fig-0001){ref-type="fig"}a, multiplex PCR screens were performed to detect *ompT, ompP*, and *arlC*. The *ompP* gene was not detected in any of the isolates (data not shown). In contrast, the *arlC* gene was present in 8 of the 58 isolates (Figure [1](#mbo3915-fig-0001){ref-type="fig"}b). Strikingly, *arlC* was only present in symptomatic isolates, which was statistically significant according to Fisher\'s exact test (*p* = .0445). Most isolates harboring the *arlC* gene also contained *ompT* and generally had higher proteolytic activity (green circles, Figure [1](#mbo3915-fig-0001){ref-type="fig"}a) than CFT073. This is consistent with the report that ArlC cleaves the FRET substrate (McPhee et al., [2014](#mbo3915-bib-0054){ref-type="ref"}). Isolate 18 from the UTI group did not have *ompT* but harbored *arlC* (Figure [1](#mbo3915-fig-0001){ref-type="fig"}b); this isolate exhibited moderate proteolytic activity (purple triangle, Figure [1](#mbo3915-fig-0001){ref-type="fig"}a). Together, these data show that among commensal and clinical isolates, higher omptin activity is associated with symptomatic disease and isolates with the greatest omptin activity harbor both the *ompT* and *arlC* genes.

3.4. Variability of ompT and arlC expression among select UPEC cystitis isolates {#mbo3915-sec-0020}
--------------------------------------------------------------------------------

To further understand omptin activity among UPEC isolates, we selected 12 isolates from the UTI group (Table [1](#mbo3915-tbl-0001){ref-type="table"}) for further analysis because they have the most heterogeneous omptin activity. The presence of *ompT* genes in these isolates was confirmed by Southern blot analysis (Figure [2](#mbo3915-fig-0002){ref-type="fig"}a). This analysis also indicated that two *ompT* genes may be present in isolates 7, 8, and 11. Consistent with the multiplex PCR results, *arlC* was detected in UTI isolates 1, 6, and 11 (Figure [2](#mbo3915-fig-0002){ref-type="fig"}a). Next, qPCR was used to measure the expression levels of *ompT* and *arlC*. In agreement with our activity assay, *ompT* transcript levels were heterogeneous among these UTI isolates (Figure [2](#mbo3915-fig-0002){ref-type="fig"}b and c). Only three isolates (2, 10, and 11) had similar expression levels to the reference strain CFT073, whereas all other isolates had higher *ompT* expression levels than the reference strain. As expected from the multiplex PCR screen and Southern blot, *arlC* expression was only detected in UTI 1, 6, and 11 isolates. UTI isolates 1 and 6, which showed the highest *ompT* and *arlC* expression levels, also had the highest omptin activity levels (Figure [2](#mbo3915-fig-0002){ref-type="fig"}c). Although both *ompT* and *arlC* are present in UTI isolate 11, they have low expression levels, which is consistent with the low omptin activity observed (Figure [2](#mbo3915-fig-0002){ref-type="fig"}c). These data indicate that heterogeneous omptin activity levels are associated with both the presence and the different expression levels of the *ompT* and *arlC* genes.

![Presence and expression of *ompT* and *arlC* among select UTI isolates. (a) Southern blot of *ompT* and *arlC* from EcoRV‐treated total DNA isolated from 12 cystitis‐causing isolates, as well as control strains CFT073, CFT073∆*ompT*, and plasmid DNA from pWSK*arlC*. (b) Quantitative real‐time PCR (qRT‐PCR) of *ompT* and *arlC* from 12 clinical isolates causing cystitis, as well as from reference strain CFT073. Shown is mean ± *SD* of *ompT* or *arlC* expression relative to *rpoD* calculated using the 2^−∆^ *^C^* ^T^ method. Data are representative of three independent experiments. (c) Omptin activity of these cystitis clinical isolates was determined by monitoring cleavage of a synthetic FRET substrate for 60 min. Shown are mean ± *SD* change in fluorescence of each cystitis isolate over the change in fluorescence of reference stain CFT073 $\left( \frac{\text{AUC\ clinical\ isolate}}{\text{AUC\ CFT}073} \right)$. Data are representative of at least three independent experiments](MBO3-8-e915-g002){#mbo3915-fig-0002}

3.5. *arlC* is present on plasmids {#mbo3915-sec-0021}
----------------------------------

To determine the genomic context of the *ompT* and *arlC* genes, isolates 1, 6, and 11 of the UTI group were sequenced on a PacBio platform. These isolates were then renamed cystitis 1, cystitis 6, and cystitis 11. Detailed descriptions of genomes and gene features are found in Appendix [1](#mbo3915-app-0001){ref-type="app"} (Figures [A1](#mbo3915-fig-0007){ref-type="fig"}a,b, [A2](#mbo3915-fig-0008){ref-type="fig"}a,b, Tables [A1](#mbo3915-tbl-0005){ref-type="table"}, [A2](#mbo3915-tbl-0006){ref-type="table"}, [A3](#mbo3915-tbl-0007){ref-type="table"}, [A4](#mbo3915-tbl-0008){ref-type="table"}, [A5](#mbo3915-tbl-0009){ref-type="table"}, [A6](#mbo3915-tbl-0010){ref-type="table"}, [A7](#mbo3915-tbl-0011){ref-type="table"}). In all three isolates, *ompT* was located within the bacterial chromosome and *arlC* was part of large plasmids (150‐195 kbp; Figures [A1](#mbo3915-fig-0007){ref-type="fig"}b and [A2](#mbo3915-fig-0008){ref-type="fig"}b). In addition, the *ompT* gene was invariably located downstream of *nfrA* and *ybcH* (Figure [3](#mbo3915-fig-0003){ref-type="fig"}a). Some differences were noted in the genomic context of *ompT* among the clinical isolates. In cystitis 1 and cystitis 6, the *envY* gene, encoding a transcriptional regulator of porin synthesis, is inserted between *ybcH* and *ompT* (182 bp downstream of *ybcH,* 512 bp upstream of *ompT*). The *appY* gene, encoding a transcriptional activator, is located 249 bp downstream of the *ompT* gene in cystitis 1, whereas *ymcE*, encoding a putative cold shock gene, is located 186 bp downstream of *ompT* in cystitis 6. In cystitis 11, the *ompT* gene is located 657 bp downstream of *ybcH* and 272 bp upstream of *ybcY*; this is the same genomic context as that in UPEC strains CFT073, UTI89, 536, J96 ABU83972 and EPEC strain e2348/69, all of which were reported to have low omptin activity (Figure [3](#mbo3915-fig-0003){ref-type="fig"}a; Brannon et al., [2013](#mbo3915-bib-0005){ref-type="ref"}; Thomassin, Brannon, Gibbs, et al., [2012](#mbo3915-bib-0073){ref-type="ref"}; Thomassin, Brannon, Kaiser, Gruenheid, & Le Moual, [2012](#mbo3915-bib-0074){ref-type="ref"})). These isolates all encode a functional *ompT* gene in their chromosomes in addition to a second truncated and, likely inactive, plasmid‐encoded *ompT* gene located adjacent to *arlC* (Figure [3](#mbo3915-fig-0003){ref-type="fig"}a,b)*.* For all isolates, the predicted amino acid sequence of ArlC is 100% identical to ArlC identified in adherent‐invasive *E. coli* (AIEC) strain NRG857c (McPhee et al., [2014](#mbo3915-bib-0054){ref-type="ref"}). Although the three plasmids harboring *arlC* were different (Figure A[2](#mbo3915-fig-0002){ref-type="fig"}a and b), *arlC* was present in all cases as part of pathogenicity island PI‐6 previously reported to play a role in AMP resistance (Figure [3](#mbo3915-fig-0003){ref-type="fig"}b (McPhee et al., [2014](#mbo3915-bib-0054){ref-type="ref"})).

![Genomic context of *arlC* and *ompT*. Schematic representation of the genomic contexts of the *ompT* (a) and *arlC* (b) genes in cystitis isolates 1, 6, and 11. Genomic contexts of *ompT* (a) and *arlC* (b) from respective reference strains CFT073 (a) and NRG857c (b) are included for comparison. Omptin genes are indicated in dark gray, light gray indicates genes located upstream and downstream of the omptin genes, stripes indicate pseudogenes, and black lines indicate intergenic space](MBO3-8-e915-g003){#mbo3915-fig-0003}

3.6. Comparative analysis of OmpT, OmpP, and ArlC {#mbo3915-sec-0022}
-------------------------------------------------

With the unexpected detection of *arlC* among the UPEC clinical isolates, we hypothesized that the presence of a second or even a third omptin protease within a single species may provide an advantage by expanding the potential range of substrates cleaved. Therefore, we sought to compare the substrate specificities of these proteases. As OmpT undergoes autocleavage during purification (Kramer, Zandwijken, Egmond, & Dekker, [2000](#mbo3915-bib-0037){ref-type="ref"}; Vandeputte‐Rutten et al., [2001](#mbo3915-bib-0076){ref-type="ref"}) and mutagenesis of residues to stabilize the protein results in a significant decrease in FRET substrate cleavage ((Kramer et al., [2000](#mbo3915-bib-0037){ref-type="ref"}); unpublished data Thomassin JL and Brannon JR), it was not possible to purify these proteases and directly compare their activities. Instead, we produced OmpT, OmpP, and ArlC in *E. coli* BL21, a laboratory strain that lacks omptin proteases. To test their production and correct localization in BL21, omptin proteins were detected by Western blot analysis from both whole cells and outer membrane preparations (Figure [4](#mbo3915-fig-0004){ref-type="fig"}a). To determine whether the proteases were active in BL21, FRET substrate cleavage was monitored over time. As expected, BL21 with empty vector did not cleave the FRET substrate, whereas the three omptins readily cleaved the FRET substrate (Figure [4](#mbo3915-fig-0004){ref-type="fig"}b). This demonstrates that when produced in BL21, ArlC, OmpP, and OmpT are found in the outer membrane and are proteolytically active.

![ArlC, OmpP, and OmpT are functional in BL21. (a) BL21 containing empty vector (ø) or plasmids encoding *arlC*, *ompP,* or *ompT* were grown until mid‐log phase and normalized to OD~595~ 0.5. Proteins from whole‐cell preparations or isolated bacterial outer membranes were resolved by SDS‐PAGE and transferred to a PVDF membrane. Omptins were detected by Western blot using anti‐CroP polyclonal antibodies. (b) A synthetic FRET peptide containing a dibasic motif (RK) was incubated with BL21 (open circles, control) or BL21 expressing *arlC* (filled squares, ArlC), *ompP* (filled circles, OmpP), or *ompT* (filled triangles, OmpT). Peptide cleavage, indicated by increased fluorescence, was monitored over time. Data show the mean ± *SD* from triplicate samples and are representative of at least three independent experiments. (c) Plasmin activation by ArlC, OmpP, and OmpT. Glu‐plasminogen and VLKpNA (plasmin substrate) were incubated with BL21 (open circles, control), BL21(p*pla*) (open triangles, Pla), BL21(p*arlC*) (filled squares, ArlC), BL21(p*ompP*) (filled circles, OmpP), or BL21(p*ompT*) (filled triangles, OmpT) strains. Absorbance at 405 nm was monitored over time. Data were normalized by subtracting initial absorbance from all values. Data represent mean ± *SD* and are representative of at least three independent experiments](MBO3-8-e915-g004){#mbo3915-fig-0004}

Omptin proteases are generally subdivided into OmpT‐like or Pla‐like subfamilies. These subfamilies differ in their ability to cleave plasminogen to activate it into active plasmin, with Pla‐like omptins producing active plasmin more readily than OmpT‐like omptins (Haiko et al., [2009](#mbo3915-bib-0019){ref-type="ref"}; Kukkonen et al., [2001](#mbo3915-bib-0038){ref-type="ref"}). To verify that the three omptin proteases belong in the OmpT‐like subfamily, we tested their ability to cleave plasminogen into plasmin. Consistent with their presence in the outer membrane, all three omptins cleaved plasminogen to a greater extent than BL21 alone (Figure [4](#mbo3915-fig-0004){ref-type="fig"}c). There was no difference in their ability to activate plasminogen. Compared with the positive control, Pla produced in BL21, the *E. coli* omptins converted significantly less plasminogen into plasmin. These data are consistent with previous publications (Brannon, Burk, et al., [2015](#mbo3915-bib-0004){ref-type="ref"}; Kukkonen et al., [2001](#mbo3915-bib-0038){ref-type="ref"}; McPhee et al., [2014](#mbo3915-bib-0054){ref-type="ref"}) and suggest that all three omptins found in *E. coli* belong to the OmpT‐like subfamily of omptin proteases.

Omptin proteases belonging to the OmpT‐like subfamily have been associated with AMP cleavage (Le Sage et al., [2009](#mbo3915-bib-0041){ref-type="ref"}; Stumpe et al., [1998](#mbo3915-bib-0069){ref-type="ref"}; Thomassin, Brannon, Gibbs, et al., [2012](#mbo3915-bib-0073){ref-type="ref"}). Previous work has shown that OmpT from EPEC, EHEC, and UPEC cleaves the human cathelicidin LL‐37. Although ArlC was shown to play a role in AMP resistance (McPhee et al., [2014](#mbo3915-bib-0054){ref-type="ref"}), and OmpT and OmpP are reported to exhibit similar substrate specificities (Hwang et al., [2007](#mbo3915-bib-0025){ref-type="ref"}; McCarter et al., [2004](#mbo3915-bib-0053){ref-type="ref"}), their ability to cleave different AMPs has not been directly compared. Therefore, we investigated the ability of the *E. coli* omptins to cleave the synthetic cationic peptide C18G and various cathelicidins Magainin II (*Xenopus laevis*), mCRAMP (*Mus musculus*), and LL‐37 (*Homo sapiens*). As expected, AMPs incubated with BL21 did not show any degradation or cleavage products, indicating that BL21 does not contain intrinsic proteases that cleave these AMPs (Figure [5](#mbo3915-fig-0005){ref-type="fig"}a). OmpT cleaved all peptides by the first time point tested (2 min C18G, 15 min mCRAMP, Magainin II, and LL‐37; Figure [5](#mbo3915-fig-0005){ref-type="fig"}a). Similar to OmpT, OmpP readily cleaved C18G and Magainin II within 2 and 30 min, respectively. In contrast, OmpP only cleaved small amounts of mCRAMP after 60 min and did not appear to cleave LL‐37 (Figure [5](#mbo3915-fig-0005){ref-type="fig"}a). ArlC cleaved mCRAMP, C18G, and Magainin II by the first time point tested (2 min C18G, 15 min mCRAMP, and Magainin II), but only a small amount of LL‐37 cleavage was observed after 60 min. Substrate properties, such as size and secondary structure, are known to influence omptin activity (Brannon, Thomassin, Gruenheid, & Le Moual, [2015](#mbo3915-bib-0006){ref-type="ref"}; Hritonenko & Stathopoulos, [2007](#mbo3915-bib-0023){ref-type="ref"}). Peptide secondary structure also influences omptin activity (Brannon, Thomassin, et al., [2015](#mbo3915-bib-0006){ref-type="ref"}); therefore, we used circular dichroism spectroscopy to determine the secondary structure of these AMPs (Figure [5](#mbo3915-fig-0005){ref-type="fig"}c). Under our experimental conditions, only LL‐37 is α‐helical, while mCRAMP, C18G, and Magainin II are unstructured (Figure [5](#mbo3915-fig-0005){ref-type="fig"}c). While peptide structure did not affect OmpT activity, ArlC did not appear to cleave the only α‐helical AMP, LL‐37 (Figure [5](#mbo3915-fig-0005){ref-type="fig"}b,c). Together, these findings suggest that OmpT, OmpP, and ArlC have differences in substrate specificities.

![ArlC, OmpP, and OmpT cleave cathelicidins. (a) AMP cleavage assay. AMPs were incubated with BL21 alone or BL21 expressing *arlC*, *ompP*, or *ompT* for the indicated times. Resulting AMP cleavage products were separated by Tris‐Tricine SDS‐PAGE, fixed with glutaraldehyde, and visualized by Coomassie staining. M indicates molecular weight marker. Data are representative of three independent experiments. (b) Amino acid sequence of AMPs cleaved in (a) with dibasic motifs highlighted in magenta and sequence length indicated in parenthesis. (c) Far UV circular dichroism spectra (200--260 nm) of the indicated peptides measured in PBS. Data were normalized by subtracting spectra from PBS alone from the sample spectra. MRE indicates degree × cm^2^ × dmol^−1^](MBO3-8-e915-g005){#mbo3915-fig-0005}

We previously reported that disulfide bonds present in defensins render them resistant to OmpT‐mediated proteolysis (Thomassin, Brannon, Kaiser, et al., [2012](#mbo3915-bib-0074){ref-type="ref"}). Yet ArlC was shown to contribute to bacterial survival in the presence of human defensins (McPhee et al., [2014](#mbo3915-bib-0054){ref-type="ref"}), suggesting that unlike OmpT, ArlC might cleave AMPs that are stabilized by disulfide bridges. RNase 7 contains four disulfide bridges and three dibasic sites (Figure [6](#mbo3915-fig-0006){ref-type="fig"}a) and is abundant in the urinary tract (Spencer et al., [2011](#mbo3915-bib-0067){ref-type="ref"}, [2013](#mbo3915-bib-0068){ref-type="ref"}). The presence of dibasic sites suggests that RNase 7 might be an omptin substrate; therefore, we sought to investigate whether there was a difference in omptin‐mediated cleavage of this peptide. Under our experimental conditions, OmpT and OmpP did not cleave RNase 7 (Figure [6](#mbo3915-fig-0006){ref-type="fig"}b). After a 60‐min incubation with ArlC, an RNase 7 cleavage product appeared, with more cleavage product appearing after 90 min. While cleavage appears limited, ArlC was the only OmpT‐like omptin able to cleave RNase 7. Taken together, these data indicate that ArlC, OmpP, and OmpT have different substrate specificities, suggesting that the presence of multiple omptin proteases in a single bacterial strain may enhance AMP resistance by increasing the range of substrates cleaved.

![ArlC cleaves RNase 7. (a) Pymol‐generated image of RNase 7 (Huang et al., [2007](#mbo3915-bib-0024){ref-type="ref"}; PDB 2hky), peptide backbone is shown in blue, cysteines and disulfide bridges are in yellow, and dibasic sites are colored magenta. Numbers correspond to the following locations of the dibasic sites in the protein sequence: 1, residues 35 and 36; 2, residues 96 and 97; and 3, residues 111 and 112. (b) Proteolytic cleavage of RNase 7. RNase 7 was incubated with BL21 containing empty vector (ø) or BL21 expressing *arlC*, *ompP*, or *ompT* for 60 or 90 min. Cleavage products (arrows) were separated by SDS‐PAGE and visualized by Coomassie staining. M indicates molecular weight marker. Data are representative of three independent experiments](MBO3-8-e915-g006){#mbo3915-fig-0006}

4. DISCUSSION {#mbo3915-sec-0023}
=============

Detection of specific genes, including *ompT*, is often used to characterize virulent clinical UPEC isolates (Johnson et al., [2001](#mbo3915-bib-0030){ref-type="ref"}; Najafi et al., [2018](#mbo3915-bib-0057){ref-type="ref"}). Previous studies have suggested that OmpT from the UPEC strain CFT073 is involved in adhesion, invasion, and/or inactivation of AMPs (Brannon et al., [2013](#mbo3915-bib-0005){ref-type="ref"}; He et al., [2015](#mbo3915-bib-0020){ref-type="ref"}). While the presence of *ompT* is associated with virulent strains, its precise contribution remains unclear, as UPEC clinical isolates have highly variable genetic sequences (Schreiber et al., [2017](#mbo3915-bib-0062){ref-type="ref"}). In addition, we previously observed large differences in OmpT protein activity due to differential *ompT* expression (Thomassin, Brannon, Gibbs, et al., [2012](#mbo3915-bib-0073){ref-type="ref"}; Thomassin, Brannon, Kaiser, et al., [2012](#mbo3915-bib-0074){ref-type="ref"}), suggesting that the presence of the *ompT* gene may not entirely correlate with its activity levels in different UPEC clinical isolates. In this study, we hypothesized that OmpT activity correlates with increased disease severity among UPEC clinical isolates. To test this hypothesis, we systematically measured omptin activity in 58 *E. coli* isolates representing colonization and a range of clinical outcomes. Increased omptin activity was correlated with clinical UPEC strains isolated from patients with symptomatic UTIs (UTI and sepsis groups).

Omptin activity was heterogeneous among the clinical isolates and could be related to differential *ompT* expression and the presence of a second OmpT‐like protease, *arlC*. For example, a 20‐fold difference in *ompT* expression was observed between isolates 5 and 11 of the UTI group (Figure [2](#mbo3915-fig-0002){ref-type="fig"}b). This finding is not unprecedented, since it was previously shown that *ompT* expression was 32‐fold higher in EHEC than in EPEC (Thomassin, Brannon, Gibbs, et al., [2012](#mbo3915-bib-0073){ref-type="ref"}). Differential *ompT* expression levels in EHEC and EPEC were attributed to differences in distal promoter sequences found more than 150 bp upstream of the *ompT* start codon (Thomassin, Brannon, Gibbs, et al., [2012](#mbo3915-bib-0073){ref-type="ref"}). An EPEC‐like *ompT* distal promoter sequence and genomic context were also correlated with low OmpT activity in UPEC reference strains (Brannon et al., [2013](#mbo3915-bib-0005){ref-type="ref"}). Therefore, it was not surprising that the EPEC‐like promoter in cystitis (UTI) isolate 11 resulted in low *ompT* expression and OmpT activity. The insertion of *envY* in the intergenic space between *nfrA* and *ompT* correlated with the increased *ompT* expression and OmpT activity levels observed in cystitis (UTI) isolates 1 and 6 (Figures [2](#mbo3915-fig-0002){ref-type="fig"}b,c and [3](#mbo3915-fig-0003){ref-type="fig"}a). These data further suggest that variations in distal promoter sequences are responsible for differential *ompT* expression and, in turn, proteolytic activity observed. It is also possible that in addition to differences in the promoter regions, transcription factors or post‐transcriptional factors regulating *ompT* expression are absent or differentially expressed in some isolates. In some cases, *ompT* expression levels did not correlate with proteolytic activity (Figure [2](#mbo3915-fig-0002){ref-type="fig"}b,c). There are several possible explanations for this observation: (a) In some isolates, *ompT* might be subjected to additional post‐transcriptional controls, (b) truncated *ompT* genes present on some of the virulence plasmids contribute to the qPCR results, (c) the presence of different surface structures prevent the peptide from accessing the OmpT active site as described by Galvàn and colleagues (Galvan, Lasaro, & Schifferli, [2008](#mbo3915-bib-0017){ref-type="ref"}), and (d) another explanation for heterogeneous omptin activity observed in this study could be attributed to the presence of a second plasmid‐encoded omptin, ArlC*,* in some isolates. The *arlC* gene was first identified as part of a large virulence plasmid of the AIEC strain NRG857c (McPhee et al., [2014](#mbo3915-bib-0054){ref-type="ref"}). BLAST searches in the NCBI database revealed that *arlC* can also be found on plasmids harbored by various human ExPEC strains isolated from patients with meningitis and sepsis, as well as avian *E. coli* strains (Figure [A2](#mbo3915-fig-0008){ref-type="fig"}). Specifically, tBLASTn search of the nonredundant plasmid database identified *arlC* in 91 instances (Galata et al., [2018](#mbo3915-bib-0016){ref-type="ref"}). The *arlC* gene is predominantly found in IncFIB (41/91) or IncFII (28/91) plasmids and less commonly in IncFIC(FII), IncQ1, IncN, or IncHI2 plasmids (13/91, 6/91, 2/91, 1/91, respectively). While we did not detect *ompP* in our study, *ompP* is present in some UPEC strains that were collected and sequenced by the Broad Institute (*E.coli* UTI Bacteremia Initiative, [2019](#mbo3915-bib-0012){ref-type="ref"}). This opens the possibility that any combination of *ompT*‐like omptin may be present in a given UPEC strain.

Omptins belonging to the OmpT‐like subfamily are known to have subtle differences in substrate specificity (Brannon, Thomassin, et al., [2015](#mbo3915-bib-0006){ref-type="ref"}; Hwang et al., [2007](#mbo3915-bib-0025){ref-type="ref"}; McCarter et al., [2004](#mbo3915-bib-0053){ref-type="ref"}). Studies using peptide libraries to compare OmpP and OmpT activity showed both omptins preferentially cleave substrates between two consecutive basic residues, but that OmpP appears to have a slight preference for Lys in the P and P' sites (Hwang et al., [2007](#mbo3915-bib-0025){ref-type="ref"}). In addition to subtle differences in amino acid motif preference, peptide size and secondary structure also impact substrate specificity (Brannon, Thomassin, et al., [2015](#mbo3915-bib-0006){ref-type="ref"}; Haiko et al., [2009](#mbo3915-bib-0019){ref-type="ref"}; Hritonenko & Stathopoulos, [2007](#mbo3915-bib-0023){ref-type="ref"}). For example, AMP α‐helicity was shown to be a determining factor for proteolytic activity of the OmpT‐like omptin, CroP, from *Citrobacter rodentium* (Brannon, Thomassin, et al., [2015](#mbo3915-bib-0006){ref-type="ref"}). While ArlC, OmpP, and OmpP all readily cleave small unstructured substrates, such as the FRET substrate and C18G, differences in cleavage efficiency were noted for larger or more structured AMPs. As all three proteases readily cleave the FRET substrate and C18G, the striking differences in ability to cleave Magainin II, mCRAMP, and LL‐37 are likely due to intrinsic differences between OmpT, OmpP, and ArlC. OmpP did not cleave Magainin II as efficiently as C18G and did not cleave larger substrates such as mCRAMP, LL‐37, and RNase 7 (Figures [4](#mbo3915-fig-0004){ref-type="fig"}a, [5](#mbo3915-fig-0005){ref-type="fig"}a,b, [6](#mbo3915-fig-0006){ref-type="fig"}b). These findings suggest that larger peptides might be excluded from the OmpP active site. While OmpT and ArlC cleaved the FRET substrate, C18G, Magainin II, and mCRAMP relatively efficiently, there was a striking difference in LL‐37 and RNase 7 cleavage (Figures [4](#mbo3915-fig-0004){ref-type="fig"}a, [5](#mbo3915-fig-0005){ref-type="fig"}a, and [6](#mbo3915-fig-0006){ref-type="fig"}b). Given the similarity in size of mCRAMP and LL‐37, and the ability of ArlC to cleave RNase 7, it is unlikely that the 3 amino acid size difference accounts for the marked difference in cleavage efficiency. It is possible that ArlC does not cleave α‐helical AMPs, but instead cleaves unstructured and disulfide bond‐stabilized peptides. While this possibility requires further study, it is supported by the finding that an *arlC* deletion strain is more susceptible to killing by human defensins (McPhee et al., [2014](#mbo3915-bib-0054){ref-type="ref"}). Altogether, these findings suggest the presence ArlC and OmpT in the same UPEC isolate may confer a fitness advantage by expanding the spectrum of target substrates.

5. CONCLUSIONS {#mbo3915-sec-0024}
==============

Here, we show that increased omptin activity is associated with UPEC strains causing symptomatic UTIs. Extensive heterogeneity of omptin activity among UPEC clinical isolates was due to variations in *ompT* expression and due to the presence of a plasmid‐encoded *ompT*‐like gene *arlC*. Our findings support current profiling practices of UPEC strains that include the *ompT* gene (Johnson & Stell, [2000](#mbo3915-bib-0031){ref-type="ref"}), but suggest that additional screening for *arlC* should be considered as both genes were exclusively harbored in UPEC strains associated with symptomatic infections. Altogether, our findings suggest that the presence of two different omptins in a UPEC strain may provide an additional fitness advantage by expanding the range of AMPs cleaved during UTIs.
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MATERIALS AND METHODS {#mbo3915-sec-0033}
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Genome analysis {#mbo3915-sec-0034}
---------------

Sequenced genomes were annotated using PATRIC (Wattam et al., [2017](#mbo3915-bib-0078){ref-type="ref"}). Isolate serotypes were determined using the online database SeroTypeFinder (Joensen, Tetzschner, Iguchi, Aarestrup, & Scheutz, [2015](#mbo3915-bib-0028){ref-type="ref"}). Strain sequence type was determined using the MLST2 server (Larsen et al., [2012](#mbo3915-bib-0039){ref-type="ref"}), and plasmids were typed using the pMLST 2.0 server (Carattoli et al., [2014](#mbo3915-bib-0007){ref-type="ref"}). Pathogenicity islands were detected using IslandViewer 4 (Bertelli et al., [2017](#mbo3915-bib-0003){ref-type="ref"}) and VRprofile 2 (Li et al., [2018](#mbo3915-bib-0043){ref-type="ref"}). Antibiotic resistance genes were identified in PATRIC, IslandViewer 4, VRprofile 2, BLAST, and RGI 4.2.2 CARD 3.0.1 (Jia et al., [2017](#mbo3915-bib-0027){ref-type="ref"}). Figures of genome alignments and plasmid alignments were generated using BRIGs software (Alikhan, Petty, Ben Zakour, & Beatson, [2011](#mbo3915-bib-0001){ref-type="ref"}).

![Comparisons of cystitis (UTI) isolate genomes with reference strains. (a) Indicated cystitis isolates were used as subject sequences in multiple sequence alignments with the indicated UPEC strain genomes using BRIGs software. White fill indicates no homology. (b) Genes amplified by multiplex PCR (*ompT, fimH, iutA, papA, papH, papC, papF, fyuA, kpsMTII, papE*, *sfaS*, *kpsMTIII*, *cnf‐1*) were used as subject sequences for a multiple sequence alignment of the indicated UPEC strain genome using BRIGs software. Black fill indicates no homology](MBO3-8-e915-g007){#mbo3915-fig-0007}

![Comparison of plasmid sequences containing pathogenicity island 6. (a) Plasmids from the indicated cystitis (UTI) isolates were used as subject sequences in multiple sequence alignments with the indicated plasmid containing pathogenicity island 6 from pO83 from *E. coli* NRG857c using BRIGs software. White fill indicates no homology. (b) Coding sequences for pathogenicity islands (PI‐) 1, 2, 3, 4, 5, and 6 from pO83 (indicated) were used as subject sequences for a multiple sequence alignment with the indicated plasmid nucleotide sequence using BRIGs software. Black fill indicates no homology](MBO3-8-e915-g008){#mbo3915-fig-0008}

###### 

General features of sequenced cystitis (UTI) isolates

  Strain        Serotype   Pathotype   Origin/disease            Phylogenetic group   Sequence type   Chromosome   Plasmid                
  ------------- ---------- ----------- ------------------------- -------------------- --------------- ------------ --------- ----- ------ ------------
  Cystitis 1    O1:H42     ExPEC       *Homo sapiens*/Cystitis   D                    648             5,083        50.5      195   49.5   F18:A‐:B1
  Cystitis 6    O82:H8     ExPEC       *Homo sapiens*/Cystitis   B1                   88              4,782        50.6      150   51.8   F16:A‐:B1
  Cystitis 11   O24:H4     ExPEC       *Homo sapiens*/Cystitis   D                    48              4,946        50.7      157   49.8   F18:A6:B42

John Wiley & Sons, Ltd

###### 

Genome features of sequenced cystitis (UTI) isolates

  Strains                                                  Cystitis 1   Cystitis 6   Cystitis 11                       
  -------------------------------------------------------- ------------ ------------ ------------- ----- ------- ----- ----
  Number of genes                                          5,148        262          4,904         236   4,865   235   
  rRNA                                                     22           0            22            0     22      0     
  tRNA                                                     88           0            91            0     89      0     
  Prophages                                                Complete     4            1             0     0       6     0
  Incomplete                                               3            1            3             1     1       1     
  Virulence factors                                        Number       249          19            242   13      217   19
  \% of genes                                              4.8          7.2          4.9           5.5   4.5     8.1   
  Genomic islands                                          12           4            11            5     15      5     
  Unique sequences[a](#mbo3915-note-0005){ref-type="fn"}   73           N/A          34            N/A   100     N/A   

N/A not applicable.

John Wiley & Sons, Ltd

###### 

Predicted genomic islands

  Isolate       Location     GI[a](#mbo3915-note-0006){ref-type="fn"}   Start       Stop        Size        \% GC   \# VG[b](#mbo3915-note-0007){ref-type="fn"}   \#AMR[c](#mbo3915-note-0008){ref-type="fn"}   tRNA         Features
  ------------- ------------ ------------------------------------------ ----------- ----------- ----------- ------- --------------------------------------------- --------------------------------------------- ------------ ------------------
  Cystitis 1    Chromosome   1                                          108,501     129,938     21,438 bp   47      6                                             0                                             seC          GI‐like region‐1
  2             147,071      185,155                                    38,085 bp   49          10          0       0                                             Prophage‐1                                                 
  3             759,876      781,233                                    21,358 bp   43          3           0       0                                             GI‐like region‐2                                           
  4             1,067,617    1,083,797                                  16,181 bp   37          0           0       0                                             T3SS‐1                                                     
  5             1,974,099    2,012,452                                  38,354 bp   49          14          0       0                                             GI‐like region‐3                                           
  6             2,496,955    2,544,448                                  47,494 bp   49          0           0       Arg                                           Prophage‐2                                                 
  7             2,715,386    2,762,418                                  47,033 bp   48          0           0       0                                             Prophage‐3                                                 
  8             2,924,030    2,960,151                                  36,122 bp   46          3           0       0                                             GI‐like region‐4                                           
  9             3,638,710    3,682,745                                  44,036 bp   51          1           1       0                                             Prophage‐4                                                 
  10            3,972,222    3,989,123                                  16,902 bp   56          0           0       0                                             T6SS‐1                                                     
  11            4,643,625    4,660,145                                  16,521 bp   49          0           0       0                                             Prophage‐5                                                 
  12            4,802,101    4,835,389                                  33,289 bp   51          1           0       0                                             Prophage‐6                                                 
  Plasmid       1            2                                          30,510      30,509 bp   53          0       0                                             0                                             T4SS‐1       
  2             35,739       41,156                                     5,417 bp    59          0           0       0                                             Integron region                                            
  3             72,375       80,367                                     7,992 bp    56          0           1       0                                             IS401                                                      
  4             134,523      141,371                                    6,848 bp    38          2           0       0                                             PAI‐6 like region                                          
  Cystitis 6    Chromosome   1                                          9,045       26,763      17,719 bp   40      0                                             0                                             0            Prophage‐1
  2             457,520      475,359                                    17,840 bp   49          2           0       0                                             GI‐like region‐1                                           
  3             897,443      919,427                                    21,985 bp   46          0           0       Arg                                           Prophage‐2                                                 
  4             1,119,747    1,142,698                                  22,952 bp   45          0           0       Thr                                           Prophage‐3                                                 
  5             1,951,044    1,969,169                                  18,126 bp   47          1           0       0                                             Prophage‐4                                                 
  6             2,249,278    2,256,258                                  6,981 bp    44          2           0       0                                             Prophage‐5                                                 
  7             2,316,877    2,325,663                                  8,787 bp    53          0           0       0                                             GI‐like region‐2                                           
  8             2,695,320    2,714,439                                  19,120 bp   51          9           0       0                                             GI‐like region‐3                                           
  9             2,728,674    2,734,357                                  5,684 bp    52          1           0       Leu                                           Prophage‐6                                                 
  10            4,256,804    4,265,449                                  8,646 bp    35          0           0       0                                             T3SS‐1                                                     
  11            4,460,470    4,468,593                                  8,124 bp    48          0           0       0                                             Prophage‐7                                                 
  Plasmid       1            216                                        5,410       5,195 bp    48          0       0                                             0                                             T4SS‐1       
  2             20,148       28,846                                     8,698       43          0           0       0                                             IS1                                                        
  3             24,163       149,472                                    24,163 bp   54          0           0       0                                             T4SS‐2                                                     
  4             38,028       42,095                                     4,234 bp    37          2           0       0                                             PAI‐6 like region                                          
  5             79,896       108,023                                    28,127 bp   60          0           5       0                                             Integron region                                            
  Cystitis 11   Chromosome   1                                          108,460     131,562     23,103 bp   47      7                                             0                                             seC          GI‐like region‐1
  2             1,043,826    1,070,085                                  26,260 bp   55          0           0       0                                             T6SS‐1                                                     
  3             1,855,773    1,873,433                                  17,661 bp   37          6           1       0                                             GI‐like region‐2                                           
  4             1,893,976    1,917,531                                  23,556 bp   51          6           0       0                                             GI‐like region‐3                                           
  5             1,969,787    2,013,948                                  44,162 bp   51          0           0       Gly                                           Prophage‐1                                                 
  6             2,068,949    2,103,765                                  34,817 bp   51          0           0       0                                             Prophage‐2                                                 
  7             2,436,309    2,488,552                                  52,244 bp   49          0           0       0                                             Prophage‐3                                                 
  8             2,834,397    2,844,341                                  9,945 bp    49          1           0       0                                             Prophage‐4                                                 
  9             3,120,160    3,147,806                                  27,647 bp   51          1           2       0                                             Prophage‐5                                                 
  10            3,245,740    3,304,629                                  58,890 bp   49          2           0       0                                             Prophage‐6                                                 
  11            3,370,608    3,382,255                                  11,648 bp   48          0           0       0                                             GI‐like region‐4                                           
  12            3,825,365    3,850,278                                  24,914 bp   49          8           0       0                                             GI‐like region‐5                                           
  13            4,115,143    4,151,037                                  35,895 bp   51          3           1       0                                             GI‐like region‐6                                           
  14            4,118,953    4,167,634                                  48,682 bp   50          1           0       Leu                                           Prophage‐7                                                 
  15            4,402,939    443,880                                    40,942 bp   43          7           0       0                                             GI‐like region‐7                                           
  Plasmid       1            5,280                                      23,125      17,846 bp   56          2       1                                             0                                             Prophage‐1   
  2             45,365       50,841                                     5,116 bp    37          2           0       0                                             PAI‐6 like region                                          
  3             82,364       87,769                                     5,405       42          0           0       0                                             IS2 and IS3                                                
  4             106,311      111,175                                    4,864       41          1           0       0                                             IS1                                                        
  5             125,191      157,658                                    32,468 bp   53          0           0       0                                             T4SS‐1                                                     

Genomic island.

VG indicates known virulence genes.

Antimicrobial resistance genes.
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###### 

Antibiotic resistance genes in cystitis (UTI) isolates

  Isolate       Location                                                                                                                                   Gene                                                                                                                                         Function; resistance mechanism                              Resistance to
  ------------- ------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------- -------------------------------------------------------------------------------------------------
  Cystitis 1    Chromosome                                                                                                                                 *acrA*                                                                                                                                       Subunit of an RND efflux pump; antibiotic efflux            Aminoglycosides
  *acrD*        Part of an RND efflux pump; antibiotic efflux                                                                                              Aminoglycosides                                                                                                                                                                                          
  *acrE*        Part of AcrEF‐TolC efflux pump; antibiotic efflux                                                                                          Fluoroquinolones, cephamycin, cephalosporin, penam                                                                                                                                                       
  *acrF*        Part of AcrEF‐TolC efflux pump; antibiotic efflux                                                                                          Fluoroquinolones, cephamycin, cephalosporin, penam                                                                                                                                                       
  *adeF*        Membrane fusion protein of the multidrug efflux complex AdeFGH; antibiotic efflux                                                          Fluoroquinolone, tetracycline                                                                                                                                                                            
  *ampC*        Enzymatic degradation of ß‐lactam rings; antibiotic inactivation                                                                           Broad and extended spectrum ß‐lactamases                                                                                                                                                                 
  *cmeB*        Inner membrane transporter in CmeABC RND efflux channel; antibiotic efflux                                                                 Cephalosporins, macrolides, fluoroquinolones, fusidic acid                                                                                                                                               
  *cmeC*        Outer membrane channel in CmeABC RND efflux channel; antibiotic efflux                                                                     Cephalosporins, macrolides, fluoroquinolones, fusidic acid                                                                                                                                               
  *cyaA*        Adenylate cyclase variant S352T; antibiotic target alteration                                                                              Fosfomycin                                                                                                                                                                                               
  *emrA*        Membrane fusion protein in EmrAB‐TolC efflux pump complex; antibiotic efflux                                                               Fluoroquinolone                                                                                                                                                                                          
  *emrB*        Translocase in EmrAB‐TolC efflux pump complex; antibiotic efflux                                                                           Fluoroquinolone                                                                                                                                                                                          
  *emrD*        Multidrug transporter that couples efflux of amphipathic compounds with proton import across the plasma membrane; antibiotic efflux        Detergents                                                                                                                                                                                               
  *emrE*        Small multidrug resistance efflux; antibiotic efflux                                                                                       Macrolides                                                                                                                                                                                               
  *emrY*        Multidrug transport across the inner membrane; antibiotic efflux                                                                           Tetracycline                                                                                                                                                                                             
  *ermK*        Membrane fusion protein that works with ErmY and TolC as part of a MFS efflux pump; antibiotic efflux                                      Tetracycline                                                                                                                                                                                             
  *ftsI*        Sequence variant D350N, S357N of PBP3; antibiotic target alteration                                                                        Cephamycin, cephalosporin, penam, carbapenam, monobactam                                                                                                                                                 
  *glpT*        Sequence variant E448K of the active importer GlpT; antibiotic target alteration                                                           Fosfomycin                                                                                                                                                                                               
  *macA*        Membrane fusion protein that acts with MacB and TolC to form an ABC antibiotic efflux complex; antibiotic efflux                           Macrolides                                                                                                                                                                                               
  *macB*        ABC transporter that acts with MacA and TolC to form an ABC antibiotic efflux complex; antibiotic efflux                                   Macrolides (14‐/15‐membered lactones)                                                                                                                                                                    
  *marA*        Regulates MDR efflux pump and regulates porin synthesis; reduced antibiotic permeability, antibiotic efflux                                Tetracycline, penem, penam, carbapenem, cephamycin, cephalosporin, rifamycin, phenicol, monobactam, glycycline, fluoroquinolone, triclosan                                                               
  *marR*        MarR variant G103S Y137H causes efflux pump overexpression; antibiotic target alteration, antibiotic efflux                                Tetracyclines, penam, cephalosporins, glycycline, rifamycin, phenicol, triclosan, fluoroquinolones                                                                                                       
  *mdfA*        Multidrug efflux pump; antibiotic efflux                                                                                                   Tetracycline, benzalkonium chloride, rhodamine                                                                                                                                                           
  *mdtA*        Membrane fusion protein RND efflux pump; antibiotic efflux                                                                                 Aminocoumarins                                                                                                                                                                                           
  *mdtB*        Transporter that forms multimeric complex with MdtC; antibiotic efflux                                                                     Aminocoumarins                                                                                                                                                                                           
  *mdtC*        Transporter that forms multimeric complex with MdtB; antibiotic efflux                                                                     Aminocoumarins                                                                                                                                                                                           
  *mdtD*        MFS transporter; antibiotic efflux                                                                                                         Aminocoumarins                                                                                                                                                                                           
  *mdtE*        Membrane fusion protein that works with MdtF and TolC as part of a MFS efflux pump; antibiotic efflux                                      Penam, fluoroquinolones, macrolides                                                                                                                                                                      
  *mdtF*        Inner membrane transporter that works with MdtE and TolC as part of a MFS efflux pump; antibiotic efflux                                   Penam, fluoroquinolones, macrolides                                                                                                                                                                      
  *mdtH*        MFS transporter; antibiotic efflux                                                                                                         Fluoroquinolones                                                                                                                                                                                         
  *mdtM*        MFS transporter; antibiotic efflux                                                                                                         Nucleosides, phenicol, lincosamides, fluoroquinolones, acridine dye                                                                                                                                      
  *mdtN*        Part of MdtNOP MFS efflux pump; antibiotic efflux                                                                                          Nucleoside antibiotics, acridine dye                                                                                                                                                                     
  *mdtO*        Part of MdtNOP MFS efflux pump; antibiotic efflux                                                                                          Nucleoside antibiotics, acridine dye                                                                                                                                                                     
  *mdtP*        Part of MdtNOP MFS efflux pump; antibiotic efflux                                                                                          Nucleoside antibiotics, acridine dye                                                                                                                                                                     
  *msbA*        Multidrug resistance transporter homolog; antibiotic efflux                                                                                Nitroimidazole                                                                                                                                                                                           
  *nfsA*        Variant Y45C of major oxygen insensitive nitroreductase in *Escherichia coli;* antibiotic target alteration                                Nitrofuran                                                                                                                                                                                               
  *pmrD*        Histidine kinase involved in regulation of polymyxin resistance; antibiotic target alteration                                              Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrF*        Glycosyl transferase; antibiotic target alteration                                                                                         Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrH*        UDP‐4‐amino‐4‐deoxy‐L‐arabinose‐oxoglutarate aminotransferase; antibiotic target alteration                                                Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrI*        UDP‐4‐amino‐4‐deoxy‐L‐arabinose formyltransferase; antibiotic target alteration                                                            Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrJ*        Catalyzes deformylation of L‐Ara4‐formyL‐N; antibiotic target alteration                                                                   Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrK*        Undecaprenyl phosphate‐alpha‐4‐amino‐4‐deoxy‐L‐arabinosyltransferase; antibiotic target alteration                                         Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrL*        Sucrose‐6 phosphate hydrolase; antibiotic target alteration                                                                                Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrM*        Subunit of undecaprenyl phosphate‐alpha‐L‐Ara4N flippase; antibiotic target alteration                                                     Polymyxins and peptide antibiotics                                                                                                                                                                       
  *sapA*        Periplasmic solute binding protein; antibiotic efflux                                                                                      Antimicrobial peptides                                                                                                                                                                                   
  *sapB*        Permease subunit; antibiotic efflux                                                                                                        Antimicrobial peptides                                                                                                                                                                                   
  *sapC*        Permease subunit; antibiotic efflux                                                                                                        Antimicrobial peptides                                                                                                                                                                                   
  *sapD*        ATPase; antibiotic efflux                                                                                                                  Antimicrobial peptides                                                                                                                                                                                   
  *sapF*        ATPase; antibiotic efflux                                                                                                                  Antimicrobial peptides                                                                                                                                                                                   
  *tufA*        Sequence variant R234F of elongation factor Tu; antibiotic target alteration                                                               Pulvomycin, elfamycin                                                                                                                                                                                    
  Cystitis 6    Chromosome                                                                                                                                 *acrA*                                                                                                                                       subunit of AcrAB‐TolC RND efflux pump; antibiotic efflux    Tetracycline, penam, cephalosporin, rifamycin, phenicol, glycycline, fluoroquinolone, triclosan
  *acrB*        subunit of AcrAB‐TolC RND efflux pump; antibiotic efflux                                                                                   Tetracycline, penam, cephalosporin, rifamycin, phenicol, glycycline, fluoroquinolone, triclosan                                                                                                          
  *acrD*        Part of an RND efflux pump; antibiotic efflux                                                                                              Aminoglycosides                                                                                                                                                                                          
  *acrE*        Part of AcrEF‐TolC RND efflux pump; antibiotic efflux                                                                                      Cephamycin, cephalosporin, penam, fluoroquinolone                                                                                                                                                        
  *acrF*        Part of AcrEF‐TolC RND efflux pump; antibiotic efflux                                                                                      Cephamycin, cephalosporin, penam, fluoroquinolone                                                                                                                                                        
  *adeF*        Membrane fusion protein of the AdeFGH RND efflux pump; antibiotic efflux                                                                   Tetracycline, fluoroquinolones                                                                                                                                                                           
  *ampC*        Enzymatic degradation of ß‐lactam rings; antibiotic inactivation                                                                           Broad and extended spectrum ß‐lactamases                                                                                                                                                                 
  *bcr*         Part of an efflux system; antibiotic efflux                                                                                                Bicyclomycins                                                                                                                                                                                            
  *cmeB*        Inner membrane transporter of the CmeABC RND efflux complex; antibiotic efflux                                                             Macrolides, cephalosporins, fusidic acid, fluoroquinolones                                                                                                                                               
  *emrA*        Part of the EmrAB‐TolC MFS efflux pump; antibiotic efflux                                                                                  Fluoroquinolones                                                                                                                                                                                         
  *emrB*        Part of the EmrAB‐TolC MFS efflux pump; antibiotic efflux                                                                                  Fluoroquinolones                                                                                                                                                                                         
  *emrK*        Part of the EmKY‐TolC MFS efflux pump; antibiotic efflux                                                                                   Tetracyclines                                                                                                                                                                                            
  *emrY*        Part of the EmKY‐TolC MFS efflux pump; antibiotic efflux                                                                                   Tetracyclines                                                                                                                                                                                            
  *ermK*        Erm 23S rRNA methyltransferase; antibiotic target alteration                                                                               Lincosamides, macrolides, streptogramins                                                                                                                                                                 
  *ftsI*        Sequence variant D350N, S357N of PBP3; antibiotic target alteration                                                                        Cephamycin, cephalosporin, penam, carbapenam, monobactam                                                                                                                                                 
  *gyrA*        Point mutation (S83L); antibiotic target modification                                                                                      Fluoroquinolones, nybomycin                                                                                                                                                                              
  *marA*        Regulates MDR efflux pump and regulates porin synthesis; reduced antibiotic permeability, antibiotic efflux                                Tetracycline, penem, penam, carbapenem, cephamycin, cephalosporin, rifamycin, phenicol, monobactam, glycycline, fluoroquinolone, triclosan                                                               
  *marR*        Regulates *marAB* operon; antibiotic target alteration, antibiotic efflux                                                                  Tetracyclines, penam, cephalosporins, glycycline, rifamycin, phenicol, triclosan, fluoroquinolones                                                                                                       
  *marR*        MarR variant G103S Y137H causes efflux pump overexpression; antibiotic target alteration, antibiotic efflux                                Tetracyclines, penam, cephalosporins, glycycline, rifamycin, phenicol, triclosan, fluoroquinolones                                                                                                       
  *mdfA*        Multidrug efflux pump; antibiotic efflux                                                                                                   Tetracycline, benzalkonium chloride, rhodamine                                                                                                                                                           
  *mdtA*        Membrane fusion protein RND efflux pump; antibiotic efflux                                                                                 Aminocoumarins                                                                                                                                                                                           
  *mdtB*        Transporter that forms multimeric complex with MdtC; antibiotic efflux                                                                     Aminocoumarins                                                                                                                                                                                           
  *mdtC*        Transporter that forms multimeric complex with MdtB; antibiotic efflux                                                                     Aminocoumarins                                                                                                                                                                                           
  *mdtE*        Membrane fusion protein that works with MdtF and TolC as part of a MFS efflux pump; antibiotic efflux                                      Penam, fluoroquinolones, macrolides                                                                                                                                                                      
  *mdtF*        Inner membrane transporter that works with MdtE and TolC as part of a MFS efflux pump; antibiotic efflux                                   Penam, fluoroquinolones, macrolides                                                                                                                                                                      
  *mdtH*        MFS transporter; antibiotic efflux                                                                                                         Fluoroquinolones                                                                                                                                                                                         
  *mdtK*        Part of a multidrug and toxic compounds extrusions transporter; antibiotic efflux                                                          Norfloxacin, doxorubicin, acriflavine                                                                                                                                                                    
  *mdtM*        MFS transporter; antibiotic efflux                                                                                                         Nucleosides, phenicol, lincosamides, fluoroquinolones, acridine dye                                                                                                                                      
  *mdtN*        Part of MdtNOP MFS efflux pump; antibiotic efflux                                                                                          Nucleoside antibiotics, acridine dye                                                                                                                                                                     
  *mdtO*        Part of MdtNOP MFS efflux pump; antibiotic efflux                                                                                          Nucleoside antibiotics, acridine dye                                                                                                                                                                     
  *mdtP*        Part of MdtNOP MFS efflux pump; antibiotic efflux                                                                                          Nucleoside antibiotics, acridine dye                                                                                                                                                                     
  *msbA*        Multidrug resistance transporter homolog; antibiotic efflux                                                                                Nitroimidazole                                                                                                                                                                                           
  *nfsA*        Variant Y45C of major oxygen insensitive nitroreductase in *Escherichia coli;* antibiotic target alteration                                Nitrofuran                                                                                                                                                                                               
  *pmrD*        Histidine kinase involved in regulation of polymyxin resistance; antibiotic target alteration                                              Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrF*        Glycosyl transferase; antibiotic target alteration                                                                                         Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrH*        UDP‐4‐amino‐4‐deoxy‐L‐arabinose‐oxoglutarate aminotransferase; antibiotic target alteration                                                Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrI*        UDP‐4‐amino‐4deoxy‐L‐arabinose formyltransferase; antibiotic target alteration                                                             Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrJ*        Catalyzes deformylation of L‐Ara4‐formyL‐N; antibiotic target alteration                                                                   Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrK*        Undecaprenyl phosphate‐alpha‐4‐amino‐4‐deoxy‐L‐arabinosyltransferase; antibiotic target alteration                                         Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrL*        Sucrose‐6 phosphate hydrolase; antibiotic target alteration                                                                                Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrM*        Subunit of undecaprenyl phosphate‐alpha‐L‐Ara4N flippase; antibiotic target alteration                                                     Polymyxins and peptide antibiotics                                                                                                                                                                       
  *tufA*        Sequence variant R234F of elongation factor Tu; antibiotic target alteration                                                               Pulvomycin, elfamycin                                                                                                                                                                                    
  Plasmid       *cmeC*                                                                                                                                     Outer membrane channel of the CmeABC RND antibiotic efflux pump; antibiotic efflux                                                           Cephalosporin, macrolides, fluoroquinolones, fusidic acid   
  *macA*        Membrane fusion protein that acts with MacB and TolC to form an ABC antibiotic efflux complex; antibiotic efflux                           Macrolides                                                                                                                                                                                               
  *macB*        ABC transporter that acts with MacA and TolC to form an ABC antibiotic efflux complex; antibiotic efflux                                   Macrolides (14‐/15‐membered lactones)                                                                                                                                                                    
  *mdtH*        MFS antibiotic efflux pump; antibiotic efflux                                                                                              Fluoroquinolones                                                                                                                                                                                         
                *aadA*                                                                                                                                     Aminoglycoside nucleotidyltransferase, antibiotic inactivation                                                                               Aminoglycosides                                             
  *dfrA12*      Dihydrofolate reductase; antibiotic target replacement                                                                                     Diaminopyrimidine                                                                                                                                                                                        
  *mphA*        Macrolide 2'‐phosphotransferase; antibiotic inactivation                                                                                   Macrolides; preferentially inactivates 14‐membered macrolides over 16‐membered macrolides                                                                                                                
  *sul1*        Dihydropteroate synthase type‐2; antibiotic target replacement                                                                             Sulfonamides, sulfone                                                                                                                                                                                    
  *tetA*        Tetracycline efflux protein TetA; antibiotic efflux                                                                                        Tetracyclines, Glycylcycline                                                                                                                                                                             
  Cystitis 11   Chromosome                                                                                                                                 *acrA*                                                                                                                                       subunit of AcrAB‐TolC RND efflux pump; antibiotic efflux    Tetracycline, penam, cephalosporin, rifamycin, phenicol, glycycline, fluoroquinolone, triclosan
  *acrB*        subunit of AcrAB‐TolC RND efflux pump; antibiotic efflux                                                                                   Tetracycline, penam, cephalosporin, rifamycin, phenicol, glycycline, fluoroquinolone, triclosan                                                                                                          
  *acrD*        RND antibiotic efflux pump; antibiotic efflux                                                                                              Aminoglycosides                                                                                                                                                                                          
  *acrE*        Membrane fusion protein of a RND efflux transporter; antibiotic efflux                                                                     Penam, cephamycin, cephalosporin, fluoroquinolones                                                                                                                                                       
  *acrF*        Inner membrane transporter component of a RND efflux transporter; antibiotic efflux                                                        Penam, cephamycin, cephalosporin, fluoroquinolones                                                                                                                                                       
  *adeF*        Membrane fusion protein of the AdeFGH RND efflux pump; antibiotic efflux                                                                   Tetracycline, fluoroquinolones                                                                                                                                                                           
  *ampC*        Class C ß‐lactamase; antibiotic inactivation                                                                                               Broad and extended spectrum cephalosporins                                                                                                                                                               
  *cmeB*        Inner membrane transporter in CmeABC RND efflux channel; antibiotic efflux                                                                 Cephalosporins, macrolides, fluoroquinolones, fusidic acid                                                                                                                                               
  *cmeC*        Outer membrane channel in CmeABC RND efflux channel; antibiotic efflux                                                                     Cephalosporins, macrolides, fluoroquinolones, fusidic acid                                                                                                                                               
  *cyaA*        Adenylate cyclase variant S352T; antibiotic target alteration                                                                              Fosfomycin                                                                                                                                                                                               
  *emrA*        Part of the EmrAB‐TolC MFS efflux pump; antibiotic efflux                                                                                  Fluoroquinolones                                                                                                                                                                                         
  *emrB*        Part of the EmrAB‐TolC MFS efflux pump; antibiotic efflux                                                                                  Fluoroquinolones                                                                                                                                                                                         
  *emrD*        Multidrug transporter that couples efflux of amphipathic compounds with proton import across the plasma membrane; antibiotic efflux        Detergents                                                                                                                                                                                               
  *emrE*        Small MDR transporter; antibiotic efflux                                                                                                   Macrolides                                                                                                                                                                                               
  *emrK*        Part of the EmKY‐TolC MFS efflux pump; antibiotic efflux                                                                                   Tetracyclines                                                                                                                                                                                            
  *emrY*        Part of the EmKY‐TolC MFS efflux pump; antibiotic efflux                                                                                   Tetracyclines                                                                                                                                                                                            
  *emrY*        MFS antibiotic efflux pump; antibiotic efflux                                                                                              Tetracyclines                                                                                                                                                                                            
  *ermA*        RNA methylase; antibiotic target alteration                                                                                                Macrolides, streptogramins, lincosamides                                                                                                                                                                 
  *ermB*        RNA methylase; antibiotic target alteration                                                                                                Macrolides, streptogramins, lincosamides                                                                                                                                                                 
  *ermK*        RNA methylase; antibiotic target alteration                                                                                                Macrolides, streptogramins, lincosamides                                                                                                                                                                 
  *ftsI*        Sequence variant D350N, S357N of PBP3; antibiotic target alteration                                                                        Cephamycin, cephalosporin, penam, carbapenam, monobactam                                                                                                                                                 
  *glpT*        Sequence variant E448K of the active importer GlpT; antibiotic target alteration                                                           Fosfomycin                                                                                                                                                                                               
  *macA*        Membrane fusion protein that acts with MacB and TolC to form an ABC antibiotic efflux complex; antibiotic efflux                           Macrolides                                                                                                                                                                                               
  *macB*        ABC transporter that acts with MacA and TolC to form an ABC antibiotic efflux complex; antibiotic efflux                                   Macrolides (14‐/15‐membered lactones)                                                                                                                                                                    
  *marA*        Global activator protein that induces MDR efflux and downregulates OmpF synthesis; reduced permeability to antibiotic, antibiotic efflux   Tetracycline, penem, penam, carbapenem, cephalosporin, rifamycin, phenicol, monobactam, glycycline, fluoroquinolone, triclosan                                                                           
  *marR*        MarR variant G103S Y137H causes efflux pump overexpression; antibiotic target alteration, antibiotic efflux                                Tetracyclines, penam, cephalosporins, glycycline, rifamycin, phenicol, triclosan, fluoroquinolones                                                                                                       
  *mdfA*        Multidrug efflux pump; antibiotic efflux                                                                                                   Tetracycline, benzalkonium chloride, rhodamine                                                                                                                                                           
  *mdtA*        Membrane fusion component of the MdtABC RND efflux pump; antibiotic efflux                                                                 Aminocoumarin resistance                                                                                                                                                                                 
  *mdtB*        Transporter in the MdtABC RND efflux pump; antibiotic efflux                                                                               Aminocoumarin resistance                                                                                                                                                                                 
  *mdtC*        Transporter in the MdtABC RND efflux pump; antibiotic efflux                                                                               Aminocoumarin resistance                                                                                                                                                                                 
  *mdtE*        Membrane fusion protein of a RND efflux transporter; antibiotic efflux                                                                     Penam, macrolides, fluoroquinolones                                                                                                                                                                      
  *mdtF*        Multidrug inner membrane transporter of an RND efflux transporter; antibiotic efflux                                                       Penam, macrolides, fluoroquinolones                                                                                                                                                                      
  *mdtH*        MFS transporter; antibiotic efflux                                                                                                         Fluoroquinolones                                                                                                                                                                                         
  *mdtM*        MFS transporter; antibiotic efflux                                                                                                         Nucleosides, phenicol, lincosamides, fluoroquinolones, acridine dye                                                                                                                                      
  *mdtN*        Predicted inner membrane fusion protein of MFS efflux pump; antibiotic efflux                                                              Nucleoside antibiotics, acridine dye                                                                                                                                                                     
  *mdtO*        Uncharacterized component of MFS efflux pump; antibiotic efflux                                                                            Nucleoside antibiotics, acridine dye                                                                                                                                                                     
  *mdtP*        Predicted outer membrane component of MFS efflux pump; antibiotic efflux                                                                   Nucleoside antibiotics, acridine dye                                                                                                                                                                     
  *msbA*        Multidrug resistance transporter homolog; antibiotic efflux                                                                                Nitroimidazole                                                                                                                                                                                           
  *nfsA*        Variant Y45C of major oxygen insensitive nitroreductase in *Escherichia coli;* antibiotic target alteration                                Nitrofuran                                                                                                                                                                                               
  *pmrD*        Histidine kinase involved in regulation of polymyxin resistance; antibiotic target alteration                                              Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrF*        Glycosyl transferase; antibiotic target alteration                                                                                         Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrH*        UDP‐4‐amino‐4‐deoxy‐L‐arabinose‐oxoglutarate aminotransferase; antibiotic target alteration                                                Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrI*        UDP‐4‐amino‐4deoxy‐L‐arabinose formyltransferase; antibiotic target alteration                                                             Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrJ*        Catalyzes deformylation of L‐Ara4‐formyL‐N; antibiotic target alteration                                                                   Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrK*        Undecaprenyl phosphate‐alpha‐4‐amino‐4‐deoxy‐L‐arabinosyltransferase; antibiotic target alteration                                         Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrL*        Sucrose‐6 phosphate hydrolase; antibiotic target alteration                                                                                Polymyxins and peptide antibiotics                                                                                                                                                                       
  *pmrM*        Subunit of undecaprenyl phosphate‐alpha‐L‐Ara4N flippase; antibiotic target alteration                                                     Polymyxins and peptide antibiotics                                                                                                                                                                       
  *sapA*        Periplasmic solute binding protein; antibiotic efflux                                                                                      Antimicrobial peptides                                                                                                                                                                                   
  *sapB*        Permease subunit; antibiotic efflux                                                                                                        Antimicrobial peptides                                                                                                                                                                                   
  *sapC*        Permease subunit; antibiotic efflux                                                                                                        Antimicrobial peptides                                                                                                                                                                                   
  *sapD*        ATPase; antibiotic efflux                                                                                                                  Antimicrobial peptides                                                                                                                                                                                   
  *sapF*        ATPase; antibiotic efflux                                                                                                                  Antimicrobial peptides                                                                                                                                                                                   
  *tetA*        Tetracycline efflux protein TetA; antibiotic efflux                                                                                        Tetracyclines, Glycylcycline                                                                                                                                                                             
  *tetB*        Part of MFS efflux pump; antibiotic efflux                                                                                                 Tetracycline, doxycycline, minocycline                                                                                                                                                                   
  *tetC*        Part of MFS efflux pump; antibiotic efflux                                                                                                 Tetracycline                                                                                                                                                                                             
  *tufA*        Sequence variant R234F of elongation factor Tu; antibiotic target alteration                                                               Pulvomycin, elfamycin                                                                                                                                                                                    
  Plasmid       *cmeC*                                                                                                                                     Outer membrane channel of the CmeABC RND antibiotic efflux pump; antibiotic efflux                                                           Cephalosporin, macrolides, fluoroquinolones, fusidic acid   
  *macA*        Membrane fusion protein that acts with MacB and TolC to form an ABC antibiotic efflux complex; antibiotic efflux                           Macrolides                                                                                                                                                                                               
  *macB*        ABC transporter that acts with MacA and TolC to form an ABC antibiotic efflux complex; antibiotic efflux                                   Macrolides (14‐/15‐membered lactones)                                                                                                                                                                    
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###### 

Unique sequences in cystitis (UTI) isolate 1

  Length[a](#mbo3915-note-0009){ref-type="fn"}   In GI[b](#mbo3915-note-0010){ref-type="fn"}   Number of genes   Description[c](#mbo3915-note-0011){ref-type="fn"}
  ---------------------------------------------- --------------------------------------------- ----------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  6,492                                          Y                                             8                 Hypothetical protein, hypothetical protein, transcriptional regulator LacI family, PTS system IIA component, putative sugar phosphoesterase component IIB, putative integral membrane protein, transketolase N‐terminal section, transketolase C‐terminal section
  10,220                                         Y/[N]{.ul}/Y                                                    Hypothetical protein, hypothetical protein, cobalt--zinc--cadmium resistance protein CzcA/ cation efflux system protein CusA, hypothetical protein, hypothetical protein, periplasmic lysozyme inhibitor of c‐type lysozyme, hypothetical protein, hypothetical protein, [N‐acetylmannosamine‐6‐phosphate 2‐epimerase, PTS system/ maltose and glucose‐specific IIC component, RpiR family transcriptional regulator, putative exported protein, probable transposase]{.ul}
  888                                            Y                                             1                 Hypothetical protein
  5,748                                          Y                                             3                 Mobile element protein, mobile element protein, AidA‐I adhesin‐like protein
  2,279                                          Y                                             2                 Beta‐1,4‐galactosyltransferase, O‐antigen ligase
  1,524                                          Y                                             2                 Hypothetical protein, hypothetical protein
  7,510                                          Y/[N]{.ul}                                    7                 DsORF‐h1, hypothetical protein, core protein, hypothetical protein, hypothetical protein, [core protein, hypothetical protein]{.ul}
  1,411                                          N                                             2                 Prophage Lp2 protein 6, hypothetical protein
  7,374                                          Y                                             7                 Integrase, hypothetical protein, tRNA‐dihydrouridine synthase, hypothetical protein, putative DNA‐binding protein, hypothetical protein, HigA (antitoxin to HigB)
  1,100                                          Y                                             2                 Hypothetical protein, hypothetical protein
  1,005                                          Y                                             1                 Transposase
  1,901                                          Y                                             2                 Hypothetical protein, hypothetical protein
  8,390                                          Y                                             6                 Type I restriction--modification system/DNA‐methyltransferase subunit M, anticodon nuclease, type I restriction--modification system/specificity subunit S, hypothetical protein, type I restriction--modification system/restriction subunit R, hypothetical protein
  1,534                                          N                                             2                 Hypothetical protein, hypothetical protein
  8,418                                          N                                             6                 Hypothetical protein, hypothetical protein, hypothetical protein, mobile element protein, beta‐1,3‐glucosyltransferase, UDP‐glucose 6‐dehydrogenase
  8,457                                          Y                                             8                 CRISPR‐associated helicase Cas3, hypothetical protein, CRISPR‐associated protein/Cse1 family, CRISPR‐associated protein/Cse2 family, CRISPR‐associated protein/ Cse4 family, CRISPR‐associated protein/ Cas5e family, CRISPR‐associated protein/Cse3 family, CRISPR‐associated protein Cas1
  2,212                                          N                                             2                 Hypothetical protein, LPS glycosyltransferase
  1,960                                          N                                             4                 Minor fimbrial subunit StfE, minor fimbrial subunit StfF, minor fimbrial subunit StfG, uncharacterized protein YadU in stf fimbrial cluster
  970                                            N                                             1                 Uncharacterized protein YehA precursor
  6,783                                          N                                             2                 Membrane protein involved in the export of O‐antigen, UDP‐N‐acetylglucosamine 2‐epimerase
  5,126                                          Y                                             3                 Aspartate ammonia‐lyase, tripeptide aminopeptidase, anaerobic C4‐dicarboxylate transporter DcuC
  2,756                                          Y                                             4                 Hypothetical protein, isoaspartyl aminopeptidase, hypothetical protein, transposase
  4,757                                          Y                                             3                 Mg(2+)‐transport‐ATPase‐associated protein MgtC, inosine--uridine preferring nucleoside hydrolase, transporter/MFS superfamily
  7,477                                          Y                                             5                 Putative transcriptional regulator LysR‐type, aspartate racemase, anaerobic C4‐dicarboxylate transporter, aspartate ammonia‐lyase, Anaerobic C4‐dicarboxylate transporter DcuB
  8,357                                          Y                                             4                 Hypothetical protein, fumarate respiration transcriptional regulator DcuR, regulatory protein GntR, anaerobic C4‐dicarboxylate transporter
  1,562                                          N                                             1                 Flagellar hook‐associated protein FliD
  558                                            N                                             1                 *Flagellar biosynthesis protein FliC*
  814                                            N                                             1                 Hypothetical protein
  12,495                                         Y                                             6                 Type I restriction--modification system/DNA‐methyltransferase subunit M, type I restriction--modification system/ specificity subunit S, hypothetical protein, hypothetical protein, type I restriction--modification system/ restriction subunit R, Putative predicted metal‐dependent hydrolase
  2,441                                          N                                             3                 Hypothetical protein, deoxyguanosinetriphosphate triphosphohydrolase, dNTP triphosphohydrolase (putative)
  546                                            Y                                             1                 Hypothetical protein
  1,681                                          Y                                             1                 Hypothetical protein
  1,355                                          Y                                             2                 TolA protein, hypothetical protein
  528                                            Y                                             0                 Part of a phage tail fiber protein
  1,047                                          Y                                             1                 Hypothetical protein
  3,301                                          N                                             3                 VgrG protein, hypothetical protein, hypothetical protein
  1,052                                          N                                             3                 Phenylacetic acid degradation protein PaaY, phenylacetic acid degradation operon negative regulatory protein PaaX, transcriptional activator feaR
  936                                            Y                                             1                 *Phage tail fiber protein*
  17,933                                         Y/[N]{.ul}/Y                                  20                Phage tail length tape‐measure protein 1, phage tail length tape‐measure protein 1, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, **Conserved hypothetical protein**, hypothetical protein, hypothetical protein, hypothetical protein, [hypothetical protein, hypothetical protein, NAD+‐‐asparagine ADP‐ribosyltransferase, 62kDa structural protein, putative phage terminase, hypothetical protein, hypothetical protein, hypothetical protein, Chromosome (plasmid) partitioning protein ParB, Trk system potassium uptake protein TrkG]{.ul}
  1,982                                          Y                                             2                 Hypothetical protein, hypothetical protein
  3,502                                          Y                                             5                 Bacteriophage‐encoded homolog of DNA replication protein DnaC, hypothetical protein, hypothetical protein, hypothetical protein, Rac prophage repressor
  759                                            Y                                             1                 Superinfection exclusion protein B
  1,167                                          Y                                             3                 Kil protein, putative bacteriophage protein, phage protein
  729                                            N                                             1                 *Exodeoxyribonuclease VIII*
  3,389                                          N                                             6                 Exodeoxyribonuclease VIII, recombinational DNA repair protein RecT, hypothetical protein, phage protein, ydaQ protein, putative lambdoid prophage Rac integrase
  19,445                                         Y                                             15                Integrase, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, unknown (no homologous in databases), DNA helicase, hypothetical protein, hypothetical protein, transposase, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein,
  19,161                                         Y                                             14                Hypothetical protein, hypothetical protein, site‐specific recombinase XerD, DNA repair protein RadC, hypothetical protein, hypothetical protein, transcriptional regulator/ (Cro/CI family), hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, type III restriction enzyme (res subunit), hypothetical protein
  9,113                                          N                                             5                 VgrG protein, hypothetical protein, Rhs family protein, hypothetical protein, Rhs family protein
  2,146                                          Y                                             2                 Hypothetical protein, hypothetical protein
  933                                            Y                                             1                 Hypothetical protein
  1,828                                          N                                             0                  
  7,085                                          N                                             5                 Protein ImpG/VasA, uncharacterized protein ImpH/VasB, type VI secretion lipoprotein/VasD, uncharacterized protein ImpJ/VasE, outer membrane protein ImpK/VasF (OmpA/MotB domain)
  3,584                                          Y                                             1                 IcmF‐related protein
  3,035                                          Y                                             2                 Secreted protein Hcp, hypothetical protein
  842                                            N                                             1                 Phosphoesterase
  1,367                                          N                                             1                 *Ferric hydroxamate outer membrane receptor FhuA*
  6,165                                          N                                             6                 Chaperone protein EcpD, outer membrane usher protein HtrE, fimbrial protein YadM, fimbrial protein YadL, fimbrial protein YadK, fimbrial protein YadC
  2,703                                          N                                             2                 Hypothetical protein, type I restriction--modification system/ restriction subunit R
  2,694                                          N                                             2                 Hypothetical protein, hypothetical protein
  5,659                                          N                                             1                 Adherence and invasion outer membrane protein (Inv, enhances Peyer\'s patches colonization)
  32,101                                         N/[Y]{.ul}                                    11                Transposase and inactivated derivative, hypothetical protein, hypothetical protein, putative DNA helicase, putative RNA helicase, type II restriction enzyme/methylase subunits, putative ATP‐dependent helicase, hypothetical protein, [hypothetical protein, putative membrane protein, outer membrane protein and related peptidoglycan‐associated (lipo)proteins, hypothetical protein]{.ul}
  571                                            Y                                             1                 ORF25
  9,482                                          Y/[N]{.ul}                                    7                 Hypothetical protein, [hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein]{.ul}
  563                                            N                                             1                 Hypothetical protein
  7,390                                          N                                             5                 IS/phage/ transposon‐related functions, hypothetical protein, hypothetical protein, core protein, core protein
  1,334                                          N                                             2                 Hypothetical protein, hypothetical protein
  831                                            N                                             1                 *Phage tail fibers*
  939                                            Y                                             1                 Hypothetical protein
  3,406                                          Y                                             3                 Hypothetical protein, hypothetical protein, DNA‐cytosine methyltransferase
  1,898                                          N                                             2                 Cox, C protein
  1,034                                          N                                             1                 Inner membrane protein
  5,750                                          N                                             6                 Putative cytoplasmic protein, hypothetical protein, putative membrane‐associated metal‐dependent hydrolase, hypothetical radical SAM family enzyme, hypothetical protein, putative hydrolase
  1,059                                          N                                             1                 Transposase
  636                                            N                                             1                 Hypothetical protein

bp.

Y: yes, N: no; underline corresponds to the underlined gene description.

Italics indicates half the coding sequence is present; bold indicates internal deletion; underlined text corresponds to the underlined GI location.
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###### 

Unique sequences in cystitis (UTI) isolate 6

  Length[a](#mbo3915-note-0012){ref-type="fn"}   In GI[b](#mbo3915-note-0013){ref-type="fn"}   Number of genes   Description[c](#mbo3915-note-0014){ref-type="fn"}
  ---------------------------------------------- --------------------------------------------- ----------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  17,937                                         Y                                             17                Hypothetical protein, hypothetical protein, putative cytoplasmic protein USSDB7A, arylsulfatase regulator, radical SAM domain heme biosynthesis protein, radical SAM domain heme biosynthesis protein, His‐Xaa‐Ser repeat protein, hypothetical protein, hypothetical protein, chromosome (plasmid) partitioning protein ParB, recombinase, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, integrase
  3,686                                          Y                                             3                 Phage DNA transfer protein, Phage DNA transfer protein, regulatory protein
  2,006                                          Y                                             1                 Phage tail fibers
  8,809                                          Y                                             9                 Asparagine synthetase \[glutamine‐hydrolyzing\], asparagine synthetase \[glutamine‐hydrolyzing\], glycerol‐3‐phosphate cytidylyltransferase, membrane protein involved in the export of O‐ antigen, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, putative N‐acetylgalactosaminyl‐diphosphoundecaprenol glucuronosyltransferase
  12,940                                         N/[Y]{.ul}                                    11                Hypothetical protein, hypothetical protein, predicted ATP‐dependent endonuclease of the OLD family, ATP‐dependent DNA helicase UvrD/PcrA, [hypothetical protein, hypothetical protein, hypothetical protein, exonuclease SbcC, hypothetical protein, hypothetical protein, hypothetical protein]{.ul}
  12,013                                         N/[Y]{.ul}                                    14                Hypothetical protein, hypothetical protein, probable monooxygenase, cysteinyl‐tRNA synthetase, [Zinc uptake regulation protein ZUR, putative metal chaperone/ involved in Zn homeostasis/ GTPase of COG0523 family, C4‐type zinc finger protein(DksA/TraR family), GTP cyclohydrolase I, GTP cyclohydrolase I, carbonic anhydrase (gamma class), NADPH‐dependent preQ0 reductase, putative inner membrane protein, manganese ABC transporter/inner membrane permease protein SitD, manganese ABC transporter/inner membrane permease protein SitC]{.ul}
  16,136                                         N/[Y]{.ul}/N                                  16                Manganese ABC transporter/ATP‐binding protein SitB, manganese ABC transporter/periplasmic‐binding protein SitA, threonyl‐tRNA synthetase, peptidase, dihydroorotase, porphobilinogen synthase, [hypothetical protein, FAD‐dependent oxidoreductase, hypothetical protein, putative secreted protein, Zinc ABC transporter/ periplasmic‐binding protein ZnuA, Zinc ABC transporter/ inner membrane permease protein ZnuB, Zinc ABC transporter/ inner membrane permease protein ZnuB, ABC transporter/ATP‐binding protein, putative phosphatase]{.ul}, putative phosphatase,
  3,203                                          N                                             2                 Flagellar hook‐associated protein FliD, flagellar biosynthesis protein FliC
  1,355                                          Y                                             2                 TolA protein, hypothetical protein
  1,368                                          Y                                             1                 Probable bacteriophage protein STY2043
  897                                            Y                                             1                 Hypothetical protein
  1,056                                          Y                                             1                 Mobile element protein
  2,161                                          Y                                             1                 Bicyclomycin resistance protein
  2,877                                          Y                                             2                 Chromosome (plasmid) partitioning protein ParB, Trk system potassium uptake protein TrkG
  724                                            Y                                             0                  
  3,611                                          Y                                             5                 Phage antitermination protein, IS/ phage/transposon‐related functions, hypothetical bacteriophage protein, putative cytoplasmic protein, hypothetical protein
  1,010                                          Y                                             2                 Hypothetical protein, LygF
  3,314                                          N                                             4                 Bacteriophage‐encoded homolog of DNA replication protein DnaC, hypothetical protein, hypothetical protein, regulatory protein Cro of bacteriophage BP‐933W
  1,049                                          N                                             2                 Phage protein, IS/ phage/transposon‐related functions
  1,167                                          N                                             2                 Kil protein, phage protein,
  747                                            N                                             1                 Exodeoxyribonuclease VIII
  3,390                                          N                                             5                 Exodeoxyribonuclease VIII, recombinational DNA repair protein RecT, phage protein, ydaQ protein, putative lambdoid prophage Rac integrase
  940                                            N                                             4                 Transposase and inactivated derivative, hypothetical protein, transposase, transposase
  1,643                                          N                                             2                 Uncharacterized protein YcdU, uncharacterized protein YmdE
  3,808                                          N                                             3                 Hypothetical protein, hypothetical protein, phage integrase/ phage P4‐associated
  1,406                                          N                                             2                 Hypothetical protein, hypothetical protein/ unknown protein (putative secreted protein)
  505                                            N                                             0                  
  1,962                                          Y                                             3                 Hypothetical protein, hypothetical protein, unknown
  1,256                                          N                                             1                 Integrase
  3,163                                          N                                             3                 TRAP‐type transport system/small permease component/predicted N‐acetylneuraminate transporter, TRAP‐type C4‐dicarboxylate transport system/ large permease component, TRAP‐type C4‐dicarboxylate transport system/ periplasmic component
  12,866                                         Y                                             17                Hypothetical protein, hypothetical protein, resolvase, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, diguanylate cyclase/phosphodiesterase (GGDEF & EAL domains) with PAS/PAC sensor(s), hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, integrase
  20,140                                         Y                                             27                Hypothetical protein, hypothetical protein, DNA‐binding protein H‐NS, hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, GALNS arylsulfatase regulator (Fe‐S oxidoreductase), hypothetical protein, hypothetical protein, thiJ/pfpI family protein, hypothetical protein, NUDIX hydrolase, Transcriptional regulator (AraC family), integral membrane protein, hypothetical protein, transcriptional regulator (AlpA like), hypothetical protein, hypothetical protein, hypothetical protein, integrase/recombinase (XerC/CodV family), putative enzyme; integration, recombination (phage or prophage related), putative enzyme; integration, recombination (phage or prophage related), putative enzyme; integration, recombination (phage or prophage related), hypothetical protein, hypothetical protein, transposase and inactivated derivatives
  898                                            Y                                             1                 Hypothetical protein

bp.

Y: yes, N: no; underline corresponds to the underlined gene description.

Underlined text corresponds to the underlined GI location.
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###### 

Unique sequences in cystitis (UTI) isolate 11

  Length[a](#mbo3915-note-0015){ref-type="fn"}   In GI[b](#mbo3915-note-0016){ref-type="fn"}   Number of genes   Description[c](#mbo3915-note-0017){ref-type="fn"}
  ---------------------------------------------- --------------------------------------------- ----------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1,154                                          Y                                             1                 Hypothetical protein
  1,329                                          Y                                             1                 Mobile element protein
  5,408                                          Y                                             6                 Hypothetical protein, hypothetical protein, DNA‐binding protein H‐NS homolog, hypothetical protein, dNTP triphosphohydrolase, hemolysin E
  6,492                                          N/[Y]{.ul}                                    8                 Hypothetical protein, hypothetical protein, transcriptional regulator LacI family, PTS system IIA component, putative sugar phosphoesterase component IIB, putative integral membrane protein, [transketolase N‐terminal section, transketolase C‐terminal section]{.ul}
  8,673                                          [Y]{.ul}/N                                    10                [Cobalt--zinc--cadmium resistance protein CzcA/cation efflux system protein CusA, hypothetical protein, hypothetical protein, periplasmic lysozyme inhibitor of c‐type lysozyme]{.ul}, hypothetical protein, hypothetical protein, N‐acetylmannosamine‐6‐phosphate 2‐epimerase, PTS system maltose and glucose‐specific IIC component, RpiR family transcriptional regulator, putative exported protein
  1,336                                          Y                                             4                 Mobile element protein, probable transposase, transposase, hypothetical protein
  888                                            Y                                             1                 Hypothetical protein
  5,755                                          Y                                             3                 Mobile element protein, mobile element protein, AidA‐I adhesin‐like protein
  2,279                                          Y                                             2                 Beta‐1,4‐galactosyltransferase, O‐antigen ligase
  1,320                                          N                                             2                 Putative cytoplasmic protein, mobile element protein
  669                                            N                                             2                 Prevent host death protein/Phd antitoxin, death on curing protein/ Doc toxin
  1,312                                          N                                             2                 Mobile element protein, putative cytoplasmic protein
  1,324                                          N                                             1                 Mobile element protein
  1,329                                          Y                                             1                 Mobile element protein
  8,372                                          Y                                             8                 Hypothetical protein, glycerol kinase, hypothetical protein, ribokinase, hypothetical protein, ADP‐ribosylglycohydrolase, fatty acyl responsive regulator, possible GPH family transporter for arabinosides
  1,328                                          N                                             1                 Mobile element protein
  1,328                                          N                                             1                 Mobile element protein
  1,240                                          N                                             1                 Hypothetical protein
  1,369                                          N                                             2                 Hypothetical protein, hypothetical protein
  1,329                                          N                                             1                 Mobile element protein
  1,329                                          N                                             1                 Putative outer membrane protein
  817                                            N                                             1                 Uncharacterized protein YadU in stf fimbrial cluster
  1,443                                          N                                             1                 Molybdate metabolism regulator
  1,329                                          Y                                             1                 Mobile element protein
  970                                            Y                                             1                 Uncharacterized protein YehA precursor
  13,828                                         Y                                             9                 Putative glycosyltransferase, mobile element protein, mobile element protein, sialic acid biosynthesis protein NeuD/O‐acetyltransferase, N‐acetylneuraminate synthase, N‐acetylneuraminate cytidylyltransferase, UDP‐N‐acetylglucosamine 2‐epimerase, hypothetical protein, N‐acetylneuraminic acid synthase‐like protein
  1,683                                          Y                                             1                 Glycosyl transferase group 1
  867                                            N                                             1                 Putative transcriptional regulator
  666                                            N                                             1                 Phage or prophage related
  759                                            N                                             1                 Bacteriophage‐encoded homolog of DNA replication protein DnaC
  652                                            N                                             0                  
  1,031                                          Y                                             2                 Hypothetical protein, hypothetical protein
  1,248                                          Y                                             1                 Phage tail fiber protein
  879                                            Y                                             1                 Mobile element protein
  1,564                                          N                                             1                 Flagellar hook‐associated protein FliD
  825                                            N                                             0                  
  1,812                                          N                                             1                 Hypothetical protein
  918                                            N                                             1                 Serine acetyltransferase
  1,196                                          N                                             1                 Hypothetical protein
  1,030                                          N                                             2                 Hypothetical protein, hypothetical protein
  3,151                                          N                                             6                 Putative DNA‐binding protein, hypothetical protein, Transcriptional regulator/XRE family, putative membrane protein, unknown protein encoded by prophage CP‐933T, putative integrase
  1,329                                          N                                             2                 Hypothetical protein, Flagellar biosynthesis protein FlhB
  1,329                                          N                                             1                 Mobile element protein
  1,329                                          N                                             1                 Mobile element protein
  1,321                                          N                                             2                 Excinuclease cho (excinuclease ABC alternative C subunit), mobile element protein
  546                                            Y                                             2                 Hypothetical protein, IS/phage/ transposon‐related functions
  1,680                                          Y                                             1                 Hypothetical protein
  1,328                                          Y                                             1                 Mobile element protein
  1,324                                          N                                             1                 Mobile element protein
  3,450                                          N                                             2                 Putative hydrolase, hypothetical protein
  9,840                                          N                                             8                 No significant similarities, hypothetical protein, hypothetical protein, Rhs family protein, VgrG protein, hypothetical protein, hypothetical protein, hypothetical protein
  1,329                                          Y                                             1                 Mobile element protein
  1,329                                          N                                             2                 Oxidoreductase (putative), mobile element protein
  1,121                                          N                                             2                 Hypothetical protein, hypothetical protein
  1,328                                          Y                                             1                 Mobile element protein
  1,329                                          N                                             1                 Mobile element protein
  1,311                                          N                                             2                 Putative cytoplasmic protein, mobile element protein
  984                                            N                                             0                  
  1,134                                          N                                             1                 Prophage Clp protease‐like protein
  1,291                                          N                                             2                 Hypothetical protein, hypothetical protein
  2,771                                          N                                             3                 Zinc binding domain/DNA primase/phage P4‐associated/replicative helicase RepA/ Pha, hypothetical protein, hypothetical protein
  1,170                                          N                                             2                 Putative ATPase component of ABC transporter with duplicated ATPase domain, L,D‐transpeptidase YbiS
  1,248                                          N                                             1                 Phage tail fiber protein
  2,030                                          Y                                             2                 Hypothetical protein, hypothetical protein
  2,095                                          Y                                             3                 Predicted transcriptional regulator, hypothetical protein, phage major capsid protein
  4,593                                          N                                             9                 Hypothetical protein, hypothetical protein, hypothetical protein, hypothetical protein, IS/ phage/ transposon‐related functions, hypothetical protein, hypothetical protein, phage DNA‐binding protein, site‐specific recombinase/phage integrase family
  705                                            Y                                             2                 Regulatory protein cro, phage repressor
  2,319                                          Y                                             3                 Hypothetical protein, phage antitermination protein N, hypothetical protein
  1,444                                          Y                                             2                 Eae protein, hypothetical protein
  1,328                                          N                                             1                 Mobile element protein
  1,653                                          Y                                             1                 Hypothetical protein
  1,394                                          Y                                             3                 No significant similarities, hypothetical protein, Rhs family protein
  6,494                                          Y                                             3                 Transposase, transposase, hypothetical protein
  2,136                                          N                                             3                 Hypothetical protein, ornithine decarboxylase, mobile element protein
  562                                            N                                             2                 Hypothetical protein, ABC‐type sugar transport system/periplasmic component
  1,329                                          N                                             1                 Mobile element protein
  614                                            Y                                             1                 Hypothetical protein
  1,328                                          Y                                             1                 Mobile element protein
  2,660                                          Y                                             2                 Mobile element protein, mobile element protein
  850                                            N                                             1                 Phosphoesterase
  1,367                                          N                                             1                 Ferric hydroxamate outer membrane receptor FhuA
  1,643                                          Y                                             1                 Hypothetical protein
  1,950                                          Y                                             1                 Hypothetical protein
  683                                            N                                             1                 Phage‐related protein
  1,505                                          N                                             1                 Hypothetical protein
  5,897                                          N                                             5                 Transcriptional regulator/RpiR family, pantothenate:Na + symporter, bona fide RidA/YjgF/TdcF/RutC subgroup, D‐aminoacylase, D‐serine deaminase
  8,320                                          N                                             5                 Hypothetical protein, hypothetical protein, hypothetical protein, type I restriction‐modification system/specificity subunit S, type I restriction--modification system/specificity subunit R
  571                                            Y                                             1                 ORF25
  1,329                                          N                                             1                 Mobile element protein
  1,228                                          N                                             1                 Hypothetical protein
  1,402                                          N                                             1                 Hypothetical protein
  16,536                                         Y/[N]{.ul}                                    11                Conserved protein of unknown function, hypothetical protein, hypothetical protein, hypothetical protein, DNA sulfur modification protein DndE, DNA sulfur modification protein DndD, 3\'‐phosphoadenosine 5\'‐phosphosulfate sulfurtransferase DndC, [DNA sulfur modification protein DndB, hypothetical protein, hypothetical protein, hypothetical protein]{.ul}
  9,146                                          Y                                             12                Mobile element protein, LysR family transcriptional regulator YeiE, hypothetical protein, sodium/glutamate symport protein, hypothetical protein, hypothetical protein, hypothetical protein, transcriptional regulator/ ArsR family, transcriptional regulator/ TetR family, tetracycline efflux protein TetA, hypothetical protein, right origin‐binding protein, mobile element protein
  1,852                                          Y                                             2                 Transposase, hypothetical protein
  2,449                                          Y                                             3                 Hypothetical protein, hypothetical protein, hypothetical protein
  5,212                                          Y                                             5                 Hypothetical protein, hypothetical protein, hypothetical protein, conserved hypothetical protein, hypothetical protein
  1,154                                          Y                                             1                 Hypothetical protein
  3,592                                          N                                             3                 Mobile element protein, Hypothetical protein, Hypothetical protein
  1,329                                          N                                             1                 Mobile element protein
  1,153                                          N                                             1                 Possible exported protein

bp.

Y: yes, N: no; underline corresponds to the underlined gene description.

Underlined text corresponds to the underlined GI location.
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